OG_ID,Component_19,group_id,apul,peve,ptua,type,avg_identity,query,accession,id,reviewed,protein_name,organism,pident,length,evalue,bitscore,title,go_ids,go_bp,go_cc,go_mf,goslim_ids,goslim_names
OG_02472,0.492204779056719,OG_02472,FUN_009674-T1,Peve_00009258,Pocillopora_meandrina_HIv1___RNAseq.g24570.t1,three_way,65.10866666666666,FUN_009674-T1,Q7ZW47,,,,,34.7,625.0,1.4e-71,272.3,sp|Q7ZW47|STAU2_DANRE Double-stranded RNA-binding protein Staufen homolog 2 OS=Danio rerio OX=7955 GN=stau2 PE=2 SV=2,,,,,,
OG_04464,0.4844936711503125,OG_04464,FUN_019346-T1,Peve_00032914,Pocillopora_meandrina_HIv1___RNAseq.g20864.t1,three_way,58.6805,FUN_019346-T1,Q80XP9,WNK3_MOUSE,,Serine/threonine-protein kinase WNK3 (EC 2.7.11.1) (Protein kinase lysine-deficient 3) (Protein kinase with no lysine 3),Mus musculus (Mouse),68.5,378.0,6e-143,510.8,sp|Q80XP9|WNK3_MOUSE Serine/threonine-protein kinase WNK3 OS=Mus musculus OX=10090 GN=Wnk3 PE=1 SV=3,GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005912; GO:0005923; GO:0006884; GO:0007231; GO:0010765; GO:0010800; GO:0035633; GO:0043066; GO:0044325; GO:0050801; GO:0051928; GO:0070294; GO:0071474; GO:0072659; GO:0090188; GO:0090279; GO:0106310; GO:0140693; GO:0140694; GO:0141109; GO:1903077; GO:1903078; GO:1904062; GO:2000651,cell volume homeostasis [GO:0006884]; cellular hyperosmotic response [GO:0071474]; maintenance of blood-brain barrier [GO:0035633]; membraneless organelle assembly [GO:0140694]; monoatomic ion homeostasis [GO:0050801]; negative regulation of apoptotic process [GO:0043066]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of protein localization to plasma membrane [GO:1903077]; osmosensory signaling pathway [GO:0007231]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to plasma membrane [GO:0072659]; regulation of calcium ion import [GO:0090279]; regulation of monoatomic cation transmembrane transport [GO:1904062]; renal sodium ion absorption [GO:0070294],adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737],ATP binding [GO:0005524]; molecular condensate scaffold activity [GO:0140693]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; transmembrane transporter binding [GO:0044325]; transporter activator activity [GO:0141109],GO:0003014; GO:0003824; GO:0016740; GO:0060090; GO:0072659; GO:0098772; GO:0140096,"renal system process; catalytic activity; transferase activity; molecular adaptor activity; protein localization to plasma membrane; molecular function regulator activity; catalytic activity, acting on a protein"
OG_03779,0.4664345850937053,OG_03779,FUN_015109-T1,Peve_00024001,Pocillopora_meandrina_HIv1___RNAseq.g21738.t1,three_way,67.93483333333333,FUN_015109-T1,Q9QXZ0,MACF1_MOUSE,,"Microtubule-actin cross-linking factor 1, isoforms 1/2/3/4 (Actin cross-linking family 7)",Mus musculus (Mouse),25.3,2944.0,1.6e-256,890.6,"sp|Q9QXZ0|MACF1_MOUSE Microtubule-actin cross-linking factor 1, isoforms 1/2/3/4 OS=Mus musculus OX=10090 GN=Macf1 PE=1 SV=2",GO:0001707; GO:0003779; GO:0005509; GO:0005737; GO:0005794; GO:0005874; GO:0005938; GO:0006620; GO:0007163; GO:0008017; GO:0008104; GO:0010632; GO:0014069; GO:0015629; GO:0015630; GO:0016020; GO:0016055; GO:0016477; GO:0016887; GO:0030177; GO:0030334; GO:0032587; GO:0032886; GO:0042060; GO:0043001; GO:0045104; GO:0051011; GO:0051015; GO:0051893; GO:0150011,cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; Golgi to plasma membrane protein transport [GO:0043001]; intermediate filament cytoskeleton organization [GO:0045104]; mesoderm formation [GO:0001707]; positive regulation of Wnt signaling pathway [GO:0030177]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; protein localization [GO:0008104]; regulation of cell migration [GO:0030334]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of microtubule-based process [GO:0032886]; regulation of neuron projection arborization [GO:0150011]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060],actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587],actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011],GO:0003824; GO:0005794; GO:0005856; GO:0007010; GO:0007163; GO:0008092; GO:0016192; GO:0016787; GO:0042060; GO:0043226; GO:0048870; GO:0072659,catalytic activity; Golgi apparatus; cytoskeleton; cytoskeleton organization; establishment or maintenance of cell polarity; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; wound healing; organelle; cell motility; protein localization to plasma membrane
OG_07641,0.4571540058690896,OG_07641,FUN_034420-T1,Peve_00021291,Pocillopora_meandrina_HIv1___RNAseq.g28575.t1,three_way,76.00066666666666,FUN_034420-T1,Q32LP4,S4A10_BOVIN,,Sodium-driven chloride bicarbonate exchanger (Solute carrier family 4 member 10),Bos taurus (Bovine),48.4,1093.0,1.6000000000000002e-273,944.1,sp|Q32LP4|S4A10_BOVIN Sodium-driven chloride bicarbonate exchanger OS=Bos taurus OX=9913 GN=SLC4A10 PE=2 SV=1,GO:0005452; GO:0005886; GO:0007601; GO:0008509; GO:0008510; GO:0015701; GO:0016323; GO:0016324; GO:0030425; GO:0036477; GO:0043025; GO:0043204; GO:0043679; GO:0045202; GO:0048172; GO:0051453; GO:0055085; GO:0098794; GO:0098982,bicarbonate transport [GO:0015701]; regulation of intracellular pH [GO:0051453]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; transmembrane transport [GO:0055085]; visual perception [GO:0007601],apical plasma membrane [GO:0016324]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; somatodendritic compartment [GO:0036477]; synapse [GO:0045202],monoatomic anion transmembrane transporter activity [GO:0008509]; sodium:bicarbonate symporter activity [GO:0008510]; solute:inorganic anion antiporter activity [GO:0005452],GO:0005215; GO:0005886; GO:0050877; GO:0055085,transporter activity; plasma membrane; nervous system process; transmembrane transport
OG_09597,0.4569890665248489,OG_09597,FUN_041744-T1,Peve_00000340,Pocillopora_meandrina_HIv1___RNAseq.g15789.t1,three_way,72.12516666666667,,,,,,,,,,,,,,,,,
OG_03674,0.4513699121575653,OG_03674,FUN_014925-T1,Peve_00006270,Pocillopora_meandrina_HIv1___RNAseq.g21082.t1,three_way,77.86116666666666,FUN_014925-T1,Q9I9E0,,,,,43.7,581.0,9.9e-52,206.5,sp|Q9I9E0|TAOK3_CHICK Serine/threonine-protein kinase TAO3 OS=Gallus gallus OX=9031 GN=TAOK3 PE=2 SV=2,,,,,,
OG_09988,0.4495104373970358,OG_09988,FUN_043182-T1,Peve_00043027,Pocillopora_meandrina_HIv1___RNAseq.g6806.t1,three_way,59.36083333333333,FUN_043182-T1,Q9Z136,,,,,38.8,361.0,3.4e-62,241.9,sp|Q9Z136|TSC1_RAT Hamartin OS=Rattus norvegicus OX=10116 GN=Tsc1 PE=1 SV=1,,,,,,
OG_02930,0.4492696069195749,OG_02930,FUN_012029-T1,Peve_00044958,Pocillopora_meandrina_HIv1___RNAseq.g24045.t1,three_way,82.663,FUN_012029-T1,P11533,,,,,29.7,3968.0,0.0,1575.5,sp|P11533|DMD_CHICK Dystrophin OS=Gallus gallus OX=9031 GN=DMD PE=2 SV=1,,,,,,
OG_07716,0.4423038586325293,OG_07716,FUN_034870-T1,Peve_00005769,Pocillopora_meandrina_HIv1___RNAseq.g27159.t1,three_way,54.551,FUN_034870-T1,Q91Y77,,,,,29.8,423.0,2.3e-49,198.7,sp|Q91Y77|MOT10_RAT Monocarboxylate transporter 10 OS=Rattus norvegicus OX=10116 GN=Slc16a10 PE=1 SV=2,,,,,,
OG_07233,0.4422475933380078,OG_07233,FUN_032906-T1,Peve_00014529,Pocillopora_meandrina_HIv1___RNAseq.g24991.t1,three_way,83.96633333333334,FUN_032906-T1,Q14671,,,,,46.1,1272.0,9e-53,210.7,sp|Q14671|PUM1_HUMAN Pumilio homolog 1 OS=Homo sapiens OX=9606 GN=PUM1 PE=1 SV=3,,,,,,
OG_09808,0.4372272451105322,OG_09808,FUN_042630-T1,Peve_00033746,Pocillopora_meandrina_HIv1___RNAseq.g11507.t1,three_way,66.90383333333334,FUN_042630-T1,Q8TEK3,DOT1L_HUMAN,,"Histone-lysine N-methyltransferase, H3 lysine-79 specific (EC 2.1.1.360) (DOT1-like protein) (Histone H3-K79 methyltransferase) (H3-K79-HMTase) (Lysine N-methyltransferase 4)",Homo sapiens (Human),42.8,636.0,2.0999999999999998e-129,465.7,"sp|Q8TEK3|DOT1L_HUMAN Histone-lysine N-methyltransferase, H3 lysine-79 specific OS=Homo sapiens OX=9606 GN=DOT1L PE=1 SV=3",GO:0000077; GO:0000781; GO:0003676; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0010467; GO:0031151; GO:0031509; GO:0032200; GO:0032259; GO:0032991; GO:0042054; GO:0043231; GO:0045944; GO:0046425; GO:0061629; GO:0140938; GO:0140956; GO:2000677,DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; gene expression [GO:0010467]; methylation [GO:0032259]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of transcription regulatory region DNA binding [GO:2000677]; subtelomeric heterochromatin formation [GO:0031509]; telomere organization [GO:0032200],"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]",DNA binding [GO:0003677]; histone H3 methyltransferase activity [GO:0140938]; histone H3K79 methyltransferase activity [GO:0031151]; histone H3K79 trimethyltransferase activity [GO:0140956]; histone methyltransferase activity [GO:0042054]; nucleic acid binding [GO:0003676]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006281; GO:0006325; GO:0006355; GO:0016740; GO:0032200; GO:0043226; GO:0060090; GO:0140096; GO:0140110,"DNA binding; catalytic activity; nucleus; nucleoplasm; DNA repair; chromatin organization; regulation of DNA-templated transcription; transferase activity; telomere organization; organelle; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_05785,0.4361991736140399,OG_05785,FUN_025760-T1,Peve_00041463,Pocillopora_meandrina_HIv1___RNAseq.g10421.t1,three_way,74.163,FUN_025760-T1,Q566I1,,,,,31.3,518.0,1.4e-47,193.0,sp|Q566I1|IN80D_XENLA INO80 complex subunit D OS=Xenopus laevis OX=8355 GN=ino80d PE=2 SV=1,,,,,,
OG_08878,0.4319784363492051,OG_08878,FUN_038277-T1,Peve_00041700,Pocillopora_meandrina_HIv1___TS.g8098.t1,three_way,74.06316666666667,FUN_038277-T1,Q0V8S9,,,,,34.8,135.0,1.4e-13,84.7,sp|Q0V8S9|CNTP5_CHICK Contactin-associated protein-like 5 OS=Gallus gallus OX=9031 GN=CNTNAP5 PE=2 SV=1,,,,,,
OG_04880,0.4309557581255104,OG_04880,FUN_022914-T1,Peve_00001826,Pocillopora_meandrina_HIv1___RNAseq.g3710.t1,three_way,80.40933333333334,FUN_022914-T1,Q63028,ADDA_RAT,,Alpha-adducin (Erythrocyte adducin subunit alpha),Rattus norvegicus (Rat),47.2,375.0,3.7e-87,323.9,sp|Q63028|ADDA_RAT Alpha-adducin OS=Rattus norvegicus OX=10116 GN=Add1 PE=1 SV=2,GO:0000902; GO:0001701; GO:0005200; GO:0005516; GO:0005634; GO:0005737; GO:0005856; GO:0005886; GO:0005912; GO:0006811; GO:0006884; GO:0007010; GO:0008290; GO:0014069; GO:0016020; GO:0020027; GO:0030218; GO:0030425; GO:0030507; GO:0030837; GO:0035264; GO:0042608; GO:0042803; GO:0043197; GO:0045202; GO:0045766; GO:0045807; GO:0046982; GO:0046983; GO:0048471; GO:0048873; GO:0051015; GO:0051016; GO:0051017; GO:0061629; GO:0071277; GO:0071300; GO:1903142; GO:1903393,actin filament bundle assembly [GO:0051017]; barbed-end actin filament capping [GO:0051016]; cell morphogenesis [GO:0000902]; cell volume homeostasis [GO:0006884]; cellular response to calcium ion [GO:0071277]; cellular response to retinoic acid [GO:0071300]; cytoskeleton organization [GO:0007010]; erythrocyte differentiation [GO:0030218]; hemoglobin metabolic process [GO:0020027]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; monoatomic ion transport [GO:0006811]; multicellular organism growth [GO:0035264]; negative regulation of actin filament polymerization [GO:0030837]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endocytosis [GO:0045807]; positive regulation of establishment of endothelial barrier [GO:1903142],adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; F-actin capping protein complex [GO:0008290]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202],actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; T cell receptor binding [GO:0042608],GO:0005198; GO:0005634; GO:0005856; GO:0005886; GO:0007010; GO:0008092; GO:0030154; GO:0043226; GO:0048856,structural molecule activity; nucleus; cytoskeleton; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; cell differentiation; organelle; anatomical structure development
OG_04165,0.4280824244111734,OG_04165,FUN_016646-T1,Peve_00042745,Pocillopora_meandrina_HIv1___RNAseq.g199.t1,three_way,51.387166666666666,FUN_016646-T1,P30173,,,,,42.1,378.0,2.2e-80,302.4,sp|P30173|ACT13_SOLTU Actin-101 OS=Solanum tuberosum OX=4113 GN=AC101 PE=3 SV=1,,,,,,
OG_02309,0.4274159729107415,OG_02309,FUN_008889-T1,Peve_00020945,Pocillopora_meandrina_HIv1___RNAseq.g4003.t1,three_way,51.47683333333334,FUN_008889-T1,D3Z8E6,CAMP1_RAT,,Calmodulin-regulated spectrin-associated protein 1,Rattus norvegicus (Rat),43.7,142.0,7.000000000000001e-32,142.1,sp|D3Z8E6|CAMP1_RAT Calmodulin-regulated spectrin-associated protein 1 OS=Rattus norvegicus OX=10116 GN=Camsap1 PE=1 SV=2,GO:0000226; GO:0005516; GO:0005737; GO:0005874; GO:0007010; GO:0007026; GO:0008017; GO:0022604; GO:0030507; GO:0031113; GO:0031122; GO:0031175; GO:0036449; GO:0051011,cytoplasmic microtubule organization [GO:0031122]; cytoskeleton organization [GO:0007010]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule depolymerization [GO:0007026]; neuron projection development [GO:0031175]; regulation of cell morphogenesis [GO:0022604]; regulation of microtubule polymerization [GO:0031113],cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule minus-end [GO:0036449],calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; spectrin binding [GO:0030507],GO:0007010; GO:0008092,cytoskeleton organization; cytoskeletal protein binding
OG_08049,0.42521759433954,OG_08049,FUN_035737-T1,Peve_00044088,Pocillopora_meandrina_HIv1___RNAseq.g11864.t1,three_way,77.52216666666666,FUN_035737-T1,Q8BYH8,CHD9_MOUSE,,Chromodomain-helicase-DNA-binding protein 9 (CHD-9) (EC 3.6.4.-) (ATP-dependent helicase CHD9) (PPAR-alpha-interacting complex protein 320 kDa) (Peroxisomal proliferator-activated receptor A-interacting complex 320 kDa protein),Mus musculus (Mouse),43.2,2161.0,0.0,1496.1,sp|Q8BYH8|CHD9_MOUSE Chromodomain-helicase-DNA-binding protein 9 OS=Mus musculus OX=10090 GN=Chd9 PE=1 SV=2,GO:0003677; GO:0004386; GO:0005524; GO:0005654; GO:0005829; GO:0006325; GO:0016887,chromatin organization [GO:0006325],cytosol [GO:0005829]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; helicase activity [GO:0004386],GO:0003677; GO:0003824; GO:0005654; GO:0005829; GO:0006325; GO:0016787; GO:0016853; GO:0140657,DNA binding; catalytic activity; nucleoplasm; cytosol; chromatin organization; hydrolase activity; isomerase activity; ATP-dependent activity
OG_09806,0.4217823549212687,OG_09806,FUN_042624-T1,Peve_00016197,Pocillopora_meandrina_HIv1___RNAseq.g11511.t1,three_way,48.837833333333336,FUN_042624-T1,E9Q414,APOB_MOUSE,,Apolipoprotein B-100 (Apo B-100) [Cleaved into: Apolipoprotein B-48 (Apo B-48)],Mus musculus (Mouse),24.7,1102.0,3e-65,254.6,sp|E9Q414|APOB_MOUSE Apolipoprotein B-100 OS=Mus musculus OX=10090 GN=Apob PE=1 SV=1,GO:0001701; GO:0005543; GO:0005576; GO:0005783; GO:0005811; GO:0005829; GO:0006629; GO:0006642; GO:0007283; GO:0007399; GO:0008201; GO:0008203; GO:0009566; GO:0009615; GO:0009791; GO:0010628; GO:0010744; GO:0010886; GO:0016042; GO:0019433; GO:0030301; GO:0030317; GO:0033344; GO:0034359; GO:0034361; GO:0034362; GO:0034363; GO:0034374; GO:0034383; GO:0035473; GO:0042157; GO:0042158; GO:0042159; GO:0042632; GO:0042953; GO:0043025; GO:0045540; GO:0048018; GO:0048844; GO:0050750; GO:0051649; GO:0070971; GO:0071402; GO:0120020,artery morphogenesis [GO:0048844]; cellular response to lipoprotein particle stimulus [GO:0071402]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; establishment of localization in cell [GO:0051649]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein catabolic process [GO:0042159]; lipoprotein metabolic process [GO:0042157]; lipoprotein transport [GO:0042953]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle remodeling [GO:0034374]; nervous system development [GO:0007399]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; post-embryonic development [GO:0009791]; regulation of cholesterol biosynthetic process [GO:0045540]; response to virus [GO:0009615]; spermatogenesis [GO:0007283]; triglyceride catabolic process [GO:0019433]; triglyceride mobilization [GO:0006642],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; extracellular region [GO:0005576]; intermediate-density lipoprotein particle [GO:0034363]; lipid droplet [GO:0005811]; low-density lipoprotein particle [GO:0034362]; mature chylomicron [GO:0034359]; neuronal cell body [GO:0043025]; very-low-density lipoprotein particle [GO:0034361],cholesterol transfer activity [GO:0120020]; heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; phospholipid binding [GO:0005543]; receptor ligand activity [GO:0048018],GO:0005215; GO:0005576; GO:0005783; GO:0005811; GO:0005829; GO:0006629; GO:0007018; GO:0008289; GO:0022414; GO:0030163; GO:0043226; GO:0048018; GO:0048856; GO:0048870; GO:0098772,transporter activity; extracellular region; endoplasmic reticulum; lipid droplet; cytosol; lipid metabolic process; microtubule-based movement; lipid binding; reproductive process; protein catabolic process; organelle; receptor ligand activity; anatomical structure development; cell motility; molecular function regulator activity
OG_07718,0.421433782394141,OG_07718,FUN_034873-T1,Peve_00005762,Pocillopora_meandrina_HIv1___RNAseq.g27162.t1,three_way,90.15966666666668,FUN_034873-T1,A1L3F5,,,,,44.8,724.0,1.6e-163,577.8,sp|A1L3F5|CMIP_XENLA C-Maf-inducing protein OS=Xenopus laevis OX=8355 GN=cmip PE=2 SV=2,,,,,,
OG_01630,0.4196907535620283,OG_01630,FUN_006744-T1,Peve_00039581,Pocillopora_meandrina_HIv1___RNAseq.g20530.t1,three_way,63.90916666666666,FUN_006744-T1,Q8BNA6,FAT3_MOUSE,,Protocadherin Fat 3 (FAT tumor suppressor homolog 3),Mus musculus (Mouse),33.8,4122.0,0.0,2094.3,sp|Q8BNA6|FAT3_MOUSE Protocadherin Fat 3 OS=Mus musculus OX=10090 GN=Fat3 PE=1 SV=2,GO:0005509; GO:0005886; GO:0007156; GO:0010842; GO:0016358; GO:0030425; GO:0048667; GO:1904936; GO:2000171,cell morphogenesis involved in neuron differentiation [GO:0048667]; dendrite development [GO:0016358]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; interneuron migration [GO:1904936]; negative regulation of dendrite development [GO:2000171]; retina layer formation [GO:0010842],dendrite [GO:0030425]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509],GO:0005886; GO:0007155; GO:0048856; GO:0048870,plasma membrane; cell adhesion; anatomical structure development; cell motility
OG_02112,0.4162402118968828,OG_02112,FUN_008397-T1,Peve_00043603,Pocillopora_meandrina_HIv1___RNAseq.g6179.t1,three_way,31.29733333333333,FUN_008397-T1,Q0P5F3,LIN7C_BOVIN,,Protein lin-7 homolog C (Lin-7C),Bos taurus (Bovine),35.4,99.0,4.4e-07,60.5,sp|Q0P5F3|LIN7C_BOVIN Protein lin-7 homolog C OS=Bos taurus OX=9913 GN=LIN7C PE=2 SV=1,GO:0005911; GO:0005923; GO:0006887; GO:0007269; GO:0008582; GO:0015031; GO:0016323; GO:0030674; GO:0043005; GO:0045202; GO:0048489; GO:0097025; GO:0098793; GO:0098839,exocytosis [GO:0006887]; neurotransmitter secretion [GO:0007269]; protein transport [GO:0015031]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; synaptic vesicle transport [GO:0048489],basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; MPP7-DLG1-LIN7 complex [GO:0097025]; neuron projection [GO:0043005]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; synapse [GO:0045202],protein-macromolecule adaptor activity [GO:0030674],GO:0016192; GO:0060090,vesicle-mediated transport; molecular adaptor activity
OG_04454,0.414369016591737,OG_04454,FUN_019134-T1,Peve_00005117,Pocillopora_meandrina_HIv1___TS.g25657.t1,three_way,65.26366666666667,FUN_019134-T1,P29294,,,,,41.9,508.0,1.3e-103,382.9,"sp|P29294|MYLK_RABIT Myosin light chain kinase, smooth muscle OS=Oryctolagus cuniculus OX=9986 GN=MYLK PE=1 SV=2",,,,,,
OG_04454,0.414369016591737,OG_04454,FUN_019134-T1,Peve_00005117,Pocillopora_meandrina_HIv1___TS.g25657.t1,three_way,65.26366666666667,FUN_019134-T1,P29294,,,,,32.7,107.0,8.6e-10,71.2,"sp|P29294|MYLK_RABIT Myosin light chain kinase, smooth muscle OS=Oryctolagus cuniculus OX=9986 GN=MYLK PE=1 SV=2",,,,,,
OG_03482,0.4142946936623456,OG_03482,FUN_014584-T1,Peve_00001487,Pocillopora_meandrina_HIv1___RNAseq.g22720.t1,three_way,49.659333333333336,FUN_014584-T1,Q1L5Z9,LONF2_HUMAN,,LON peptidase N-terminal domain and RING finger protein 2 (Neuroblastoma apoptosis-related protease) (RING finger protein 192),Homo sapiens (Human),31.0,625.0,2.6999999999999993e-68,261.5,sp|Q1L5Z9|LONF2_HUMAN LON peptidase N-terminal domain and RING finger protein 2 OS=Homo sapiens OX=9606 GN=LONRF2 PE=1 SV=3,GO:0005737; GO:0006515; GO:0008270; GO:0021522; GO:0031175; GO:0043021; GO:0043524; GO:0050905; GO:0051402; GO:0051787; GO:0061630; GO:0061744,motor behavior [GO:0061744]; negative regulation of neuron apoptotic process [GO:0043524]; neuromuscular process [GO:0050905]; neuron apoptotic process [GO:0051402]; neuron projection development [GO:0031175]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; spinal cord motor neuron differentiation [GO:0021522],cytoplasm [GO:0005737],misfolded protein binding [GO:0051787]; ribonucleoprotein complex binding [GO:0043021]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0012501; GO:0016740; GO:0030154; GO:0050877; GO:0140096,"catalytic activity; programmed cell death; transferase activity; cell differentiation; nervous system process; catalytic activity, acting on a protein"
OG_04359,0.4132650799752208,OG_04359,FUN_018010-T1,Peve_00000404,Pocillopora_meandrina_HIv1___RNAseq.g25255.t4,three_way,81.14033333333334,FUN_018010-T1,A2CG49,,,,,35.3,3036.0,0.0,1707.6,sp|A2CG49|KALRN_MOUSE Kalirin OS=Mus musculus OX=10090 GN=Kalrn PE=1 SV=1,,,,,,
OG_06004,0.4116776295449174,OG_06004,FUN_026494-T1,Peve_00004180,Pocillopora_meandrina_HIv1___RNAseq.g4199.t1,three_way,63.488,FUN_026494-T1,Q71M21,,,,,28.2,1343.0,2.3000000000000001e-88,329.7,sp|Q71M21|RH21B_XENLA Rho GTPase-activating protein 21-B OS=Xenopus laevis OX=8355 GN=arhgap21-b PE=2 SV=1,,,,,,
OG_04759,0.4079313803160345,OG_04759,FUN_022649-T1,Peve_00019793,Pocillopora_meandrina_HIv1___RNAseq.g4450.t2,three_way,87.07466666666667,FUN_022649-T1,Q6ZWH5,NEK10_HUMAN,,Serine/threonine-protein kinase Nek10 (EC 2.7.11.1) (Never in mitosis A-related kinase 10) (NimA-related protein kinase 10),Homo sapiens (Human),45.7,1046.0,4.3e-211,736.5,sp|Q6ZWH5|NEK10_HUMAN Serine/threonine-protein kinase Nek10 OS=Homo sapiens OX=9606 GN=NEK10 PE=1 SV=3,GO:0004672; GO:0004674; GO:0005524; GO:0005576; GO:0006468; GO:0031954; GO:0043406; GO:0046872; GO:0070372; GO:0106310; GO:0120197; GO:1902749; GO:1902911,mucociliary clearance [GO:0120197]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein autophosphorylation [GO:0031954]; protein phosphorylation [GO:0006468]; regulation of cell cycle G2/M phase transition [GO:1902749]; regulation of ERK1 and ERK2 cascade [GO:0070372],extracellular region [GO:0005576]; protein kinase complex [GO:1902911],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003016; GO:0003824; GO:0005576; GO:0007018; GO:0016740; GO:0140096,"respiratory system process; catalytic activity; extracellular region; microtubule-based movement; transferase activity; catalytic activity, acting on a protein"
OG_05958,0.4067733564741577,OG_05958,FUN_026305-T1,Peve_00025709,Pocillopora_meandrina_HIv1___RNAseq.g3058.t1,three_way,89.43866666666666,FUN_026305-T1,P21613,,,,,58.8,972.0,2.4e-239,830.5,sp|P21613|KINH_DORPE Kinesin heavy chain OS=Doryteuthis pealeii OX=1051067 PE=1 SV=1,,,,,,
OG_01522,0.4067223334945673,OG_01522,FUN_006276-T1,Peve_00031100,Pocillopora_meandrina_HIv1___RNAseq.g20369.t1,three_way,84.9125,FUN_006276-T1,Q8K5C0,GRHL2_MOUSE,,Grainyhead-like protein 2 homolog (Brother of mammalian grainyhead) (Transcription factor CP2-like 3),Mus musculus (Mouse),32.7,620.0,2.6999999999999998e-70,268.1,sp|Q8K5C0|GRHL2_MOUSE Grainyhead-like protein 2 homolog OS=Mus musculus OX=10090 GN=Grhl2 PE=2 SV=1,GO:0001161; GO:0001228; GO:0001701; GO:0001843; GO:0003208; GO:0003382; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005911; GO:0006355; GO:0006357; GO:0007155; GO:0007420; GO:0008544; GO:0010468; GO:0016020; GO:0021915; GO:0030216; GO:0030323; GO:0031490; GO:0034329; GO:0035264; GO:0042733; GO:0042802; GO:0043010; GO:0043565; GO:0045893; GO:0045944; GO:0048568; GO:0048701; GO:0060324; GO:0060463; GO:0060487; GO:0060672; GO:0061713; GO:0070830; GO:0090132; GO:0140297,anterior neural tube closure [GO:0061713]; bicellular tight junction assembly [GO:0070830]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; cardiac ventricle morphogenesis [GO:0003208]; cell adhesion [GO:0007155]; cell junction assembly [GO:0034329]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; embryonic organ development [GO:0048568]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; epithelial cell morphogenesis involved in placental branching [GO:0060672]; epithelium migration [GO:0090132]; face development [GO:0060324]; in utero embryonic development [GO:0001701]; keratinocyte differentiation [GO:0030216]; lung epithelial cell differentiation [GO:0060487]; lung lobe morphogenesis [GO:0060463]; multicellular organism growth [GO:0035264]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory tube development [GO:0030323],cell-cell junction [GO:0005911]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; intronic transcription regulatory region sequence-specific DNA binding [GO:0001161]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0007155; GO:0030154; GO:0034330; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; cell adhesion; cell differentiation; cell junction organization; organelle; anatomical structure development; transcription regulator activity
OG_04351,0.4065272074682835,OG_04351,FUN_017990-T1,Peve_00037470,Pocillopora_meandrina_HIv1___RNAseq.g25285.t1,three_way,80.066,FUN_017990-T1,Q16665,,,,,40.2,388.0,3.2e-77,291.2,sp|Q16665|HIF1A_HUMAN Hypoxia-inducible factor 1-alpha OS=Homo sapiens OX=9606 GN=HIF1A PE=1 SV=1,,,,,,
OG_06372,0.4065087792628509,OG_06372,FUN_028977-T1,Peve_00014804,Pocillopora_meandrina_HIv1___RNAseq.g25607.t1,three_way,64.57616666666667,FUN_028977-T1,Q3UG20,KMT2E_MOUSE,,Inactive histone-lysine N-methyltransferase 2E (Inactive lysine N-methyltransferase 2E) (Myeloid/lymphoid or mixed-lineage leukemia protein 5 homolog),Mus musculus (Mouse),30.4,460.0,1e-47,194.1,sp|Q3UG20|KMT2E_MOUSE Inactive histone-lysine N-methyltransferase 2E OS=Mus musculus OX=10090 GN=Kmt2e PE=1 SV=2,GO:0000791; GO:0002446; GO:0003713; GO:0005737; GO:0005813; GO:0008270; GO:0016607; GO:0019899; GO:0030218; GO:0032991; GO:0035064; GO:0040029; GO:0042119; GO:0042800; GO:0045893; GO:0048384; GO:1900087,epigenetic regulation of gene expression [GO:0040029]; erythrocyte differentiation [GO:0030218]; neutrophil activation [GO:0042119]; neutrophil mediated immunity [GO:0002446]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; retinoic acid receptor signaling pathway [GO:0048384],centrosome [GO:0005813]; cytoplasm [GO:0005737]; euchromatin [GO:0000791]; nuclear speck [GO:0016607]; protein-containing complex [GO:0032991],enzyme binding [GO:0019899]; histone H3K4 methyltransferase activity [GO:0042800]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005815; GO:0006325; GO:0006355; GO:0016740; GO:0030154; GO:0043226; GO:0060090; GO:0140096; GO:0140110,"immune system process; catalytic activity; microtubule organizing center; chromatin organization; regulation of DNA-templated transcription; transferase activity; cell differentiation; organelle; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_04983,0.4055759057561268,OG_04983,FUN_023110-T1,Peve_00000494,Pocillopora_meandrina_HIv1___RNAseq.g1701.t2,three_way,63.913,FUN_023110-T1,Q8IUR6,,,,,61.0,59.0,2e-11,71.6,sp|Q8IUR6|CRERF_HUMAN CREB3 regulatory factor OS=Homo sapiens OX=9606 GN=CREBRF PE=1 SV=2,,,,,,
OG_06571,0.4035254374910201,OG_06571,FUN_029484-T1,Peve_00017245,Pocillopora_meandrina_HIv1___RNAseq.g17128.t1,three_way,64.353,FUN_029484-T1,Q8NEA6,GLIS3_HUMAN,,Zinc finger protein GLIS3 (GLI-similar 3) (Zinc finger protein 515),Homo sapiens (Human),64.3,70.0,4.8e-23,110.9,sp|Q8NEA6|GLIS3_HUMAN Zinc finger protein GLIS3 OS=Homo sapiens OX=9606 GN=GLIS3 PE=1 SV=5,GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0005634; GO:0006357; GO:0006366; GO:0008270; GO:0045944,negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366],nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0006351; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; DNA-templated transcription; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_01314,0.4022073277094747,OG_01314,FUN_005177-T1,Peve_00022720,Pocillopora_meandrina_HIv1___RNAseq.g7584.t1,three_way,78.689,FUN_005177-T1,Q7Z401,MYCPP_HUMAN,,C-myc promoter-binding protein (DENN domain-containing protein 4A),Homo sapiens (Human),34.8,1885.0,8.6e-282,971.8,sp|Q7Z401|MYCPP_HUMAN C-myc promoter-binding protein OS=Homo sapiens OX=9606 GN=DENND4A PE=1 SV=2,GO:0003677; GO:0005085; GO:0005634; GO:0005829; GO:0006355; GO:0031410; GO:0032483,regulation of DNA-templated transcription [GO:0006355]; regulation of Rab protein signal transduction [GO:0032483],cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634],DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085],GO:0003677; GO:0005634; GO:0005829; GO:0006355; GO:0031410; GO:0043226; GO:0098772,DNA binding; nucleus; cytosol; regulation of DNA-templated transcription; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_00388,0.4010764280946303,OG_00388,FUN_001241-T1,Peve_00022814,Pocillopora_meandrina_HIv1___TS.g4819.t1,three_way,90.189,FUN_001241-T1,Q5BJ41,CNOT6_XENLA,,CCR4-NOT transcription complex subunit 6 (EC 3.1.13.4) (Cytoplasmic deadenylase),Xenopus laevis (African clawed frog),59.0,558.0,8e-140,498.8,sp|Q5BJ41|CNOT6_XENLA CCR4-NOT transcription complex subunit 6 OS=Xenopus laevis OX=8355 GN=cnot6 PE=1 SV=1,GO:0000175; GO:0000289; GO:0003713; GO:0003723; GO:0004532; GO:0004535; GO:0005634; GO:0005737; GO:0006417; GO:0030014; GO:0035279; GO:0046872; GO:0070966,"miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; regulation of translation [GO:0006417]",CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; nucleus [GO:0005634],3'-5'-RNA exonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; RNA exonuclease activity [GO:0004532]; transcription coactivator activity [GO:0003713],GO:0003723; GO:0003824; GO:0005634; GO:0016071; GO:0016787; GO:0031047; GO:0043226; GO:0060090; GO:0140098; GO:0140110,"RNA binding; catalytic activity; nucleus; mRNA metabolic process; hydrolase activity; regulatory ncRNA-mediated gene silencing; organelle; molecular adaptor activity; catalytic activity, acting on RNA; transcription regulator activity"
OG_06109,0.4001772499796116,OG_06109,FUN_027814-T1,Peve_00036499,Pocillopora_meandrina_HIv1___RNAseq.g13890.t1,three_way,84.264,FUN_027814-T1,O00571,DDX3X_HUMAN,,"ATP-dependent RNA helicase DDX3X (EC 3.6.4.13) (CAP-Rf) (DEAD box protein 3, X-chromosomal) (DEAD box, X isoform) (DBX) (Helicase-like protein 2) (HLP2)",Homo sapiens (Human),71.5,425.0,1.6999999999999996e-177,623.6,sp|O00571|DDX3X_HUMAN ATP-dependent RNA helicase DDX3X OS=Homo sapiens OX=9606 GN=DDX3X PE=1 SV=3,GO:0002753; GO:0003677; GO:0003678; GO:0003723; GO:0003724; GO:0003729; GO:0003924; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0006413; GO:0007059; GO:0007276; GO:0008134; GO:0008143; GO:0008190; GO:0008625; GO:0009615; GO:0010494; GO:0010628; GO:0010629; GO:0016055; GO:0016887; GO:0017111; GO:0017148; GO:0030027; GO:0030154; GO:0030307; GO:0030308; GO:0031252; GO:0031333; GO:0031369; GO:0032481; GO:0032727; GO:0032728; GO:0033592; GO:0034063; GO:0034157; GO:0034161; GO:0034774; GO:0035556; GO:0035591; GO:0035613; GO:0036493; GO:0042256; GO:0043015; GO:0043024; GO:0043065; GO:0043066; GO:0043186; GO:0043273; GO:0043539; GO:0045070; GO:0045087; GO:0045296; GO:0045727; GO:0045944; GO:0045948; GO:0048027; GO:0055088; GO:0070062; GO:0070131; GO:0071243; GO:0071470; GO:0071651; GO:0072559; GO:0090263; GO:0097193; GO:0098586; GO:1900087; GO:1900227; GO:1901223; GO:1901224; GO:1902042; GO:1902523; GO:1903608; GO:1904813; GO:2001243,cell differentiation [GO:0030154]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to osmotic stress [GO:0071470]; cellular response to virus [GO:0098586]; chromosome segregation [GO:0007059]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; cytosolic ribosome assembly [GO:0042256]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; gamete generation [GO:0007276]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway [GO:0097193]; lipid homeostasis [GO:0055088]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of translation [GO:0017148]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of chemokine (C-C motif) ligand 5 production [GO:0071651]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of mitochondrial translation [GO:0070131]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; positive regulation of translational initiation [GO:0045948]; positive regulation of type I interferon production [GO:0032481]; positive regulation of viral genome replication [GO:0045070]; protein localization to cytoplasmic stress granule [GO:1903608]; response to virus [GO:0009615]; stress granule assembly [GO:0034063]; translational initiation [GO:0006413]; Wnt signaling pathway [GO:0016055],cell leading edge [GO:0031252]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lamellipodium [GO:0030027]; mitochondrion [GO:0005739]; NLRP3 inflammasome complex [GO:0072559]; nucleus [GO:0005634]; P granule [GO:0043186]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cadherin binding [GO:0045296]; CTPase activity [GO:0043273]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; eukaryotic initiation factor 4E binding [GO:0008190]; gamma-tubulin binding [GO:0043015]; GTPase activity [GO:0003924]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; protein serine/threonine kinase activator activity [GO:0043539]; ribonucleoside triphosphate phosphatase activity [GO:0017111]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA stem-loop binding [GO:0035613]; RNA strand annealing activity [GO:0033592]; signaling adaptor activity [GO:0035591]; transcription factor binding [GO:0008134]; translation initiation factor binding [GO:0031369],GO:0002376; GO:0003677; GO:0003723; GO:0003824; GO:0003924; GO:0005576; GO:0005634; GO:0005739; GO:0005815; GO:0005829; GO:0005886; GO:0006355; GO:0007059; GO:0008092; GO:0016787; GO:0016853; GO:0022414; GO:0030154; GO:0043226; GO:0060090; GO:0098542; GO:0098772; GO:0140097; GO:0140098; GO:0140657,"immune system process; DNA binding; RNA binding; catalytic activity; GTPase activity; extracellular region; nucleus; mitochondrion; microtubule organizing center; cytosol; plasma membrane; regulation of DNA-templated transcription; chromosome segregation; cytoskeletal protein binding; hydrolase activity; isomerase activity; reproductive process; cell differentiation; organelle; molecular adaptor activity; defense response to other organism; molecular function regulator activity; catalytic activity, acting on DNA; catalytic activity, acting on RNA; ATP-dependent activity"
OG_00402,0.3992942180045061,OG_00402,FUN_001289-T1,Peve_00037015,Pocillopora_meandrina_HIv1___TS.g4708.t1a,three_way,81.49916666666667,FUN_001289-T1,Q9ULJ6,,,,,45.5,1166.0,3.5e-155,550.8,sp|Q9ULJ6|ZMIZ1_HUMAN Zinc finger MIZ domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ZMIZ1 PE=1 SV=3,,,,,,
OG_09596,0.3992828760125964,OG_09596,FUN_041743-T1,Peve_00002188,Pocillopora_meandrina_HIv1___RNAseq.g15788.t1,three_way,64.87933333333334,,,,,,,,,,,,,,,,,
OG_01324,0.3981517400686992,OG_01324,FUN_005194-T1,Peve_00001277,Pocillopora_meandrina_HIv1___RNAseq.g15136.t1,three_way,66.81283333333333,,,,,,,,,,,,,,,,,
OG_05881,0.3978523639967909,OG_05881,FUN_026034-T1,Peve_00022184,Pocillopora_meandrina_HIv1___RNAseq.g10547.t1,three_way,87.94766666666666,FUN_026034-T1,P29074,PTN4_HUMAN,,Tyrosine-protein phosphatase non-receptor type 4 (EC 3.1.3.48) (Protein-tyrosine phosphatase MEG1) (MEG) (PTPase-MEG1),Homo sapiens (Human),43.1,929.0,2e-217,757.3,sp|P29074|PTN4_HUMAN Tyrosine-protein phosphatase non-receptor type 4 OS=Homo sapiens OX=9606 GN=PTPN4 PE=1 SV=1,GO:0004725; GO:0004726; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006470; GO:0008092; GO:0009898; GO:0035254,protein dephosphorylation [GO:0006470],cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654],cytoskeletal protein binding [GO:0008092]; glutamate receptor binding [GO:0035254]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725],GO:0003824; GO:0005654; GO:0005829; GO:0005856; GO:0008092; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleoplasm; cytosol; cytoskeleton; cytoskeletal protein binding; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_00154,0.3968988073488018,OG_00154,FUN_000608-T1,Peve_00041270,Pocillopora_meandrina_HIv1___RNAseq.g2496.t1,three_way,75.2995,FUN_000608-T1,G3MWR8,MICA3_BOVIN,,[F-actin]-monooxygenase MICAL3 (EC 1.14.13.225) (Molecule interacting with CasL protein 3) (MICAL-3),Bos taurus (Bovine),47.8,912.0,6.499999999999998e-229,796.2,sp|G3MWR8|MICA3_BOVIN [F-actin]-monooxygenase MICAL3 OS=Bos taurus OX=9913 GN=MICAL3 PE=3 SV=1,GO:0003779; GO:0005634; GO:0005819; GO:0005938; GO:0006887; GO:0007010; GO:0016709; GO:0030042; GO:0030496; GO:0042995; GO:0046872; GO:0071949; GO:0120501,actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; exocytosis [GO:0006887],cell cortex [GO:0005938]; cell projection [GO:0042995]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819],"actin binding [GO:0003779]; F-actin monooxygenase activity [GO:0120501]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]",GO:0003824; GO:0005634; GO:0007010; GO:0008092; GO:0016192; GO:0016491; GO:0043226,catalytic activity; nucleus; cytoskeleton organization; cytoskeletal protein binding; vesicle-mediated transport; oxidoreductase activity; organelle
OG_00154,0.3968988073488018,OG_00154,FUN_000608-T1,Peve_00041270,Pocillopora_meandrina_HIv1___RNAseq.g2496.t1,three_way,75.2995,FUN_000608-T1,G3MWR8,MICA3_BOVIN,,[F-actin]-monooxygenase MICAL3 (EC 1.14.13.225) (Molecule interacting with CasL protein 3) (MICAL-3),Bos taurus (Bovine),37.4,286.0,1.3e-27,127.5,sp|G3MWR8|MICA3_BOVIN [F-actin]-monooxygenase MICAL3 OS=Bos taurus OX=9913 GN=MICAL3 PE=3 SV=1,GO:0003779; GO:0005634; GO:0005819; GO:0005938; GO:0006887; GO:0007010; GO:0016709; GO:0030042; GO:0030496; GO:0042995; GO:0046872; GO:0071949; GO:0120501,actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; exocytosis [GO:0006887],cell cortex [GO:0005938]; cell projection [GO:0042995]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819],"actin binding [GO:0003779]; F-actin monooxygenase activity [GO:0120501]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]",GO:0003824; GO:0005634; GO:0007010; GO:0008092; GO:0016192; GO:0016491; GO:0043226,catalytic activity; nucleus; cytoskeleton organization; cytoskeletal protein binding; vesicle-mediated transport; oxidoreductase activity; organelle
OG_02454,0.3968366628771556,OG_02454,FUN_009532-T1,Peve_00009560,Pocillopora_meandrina_HIv1___RNAseq.g24493.t1,three_way,88.02533333333334,FUN_009532-T1,Q148N0,,,,,64.9,976.0,0.0,1304.7,sp|Q148N0|ODO1_BOVIN 2-oxoglutarate dehydrogenase complex component E1 OS=Bos taurus OX=9913 GN=OGDH PE=1 SV=1,,,,,,
OG_04746,0.3964203558175507,OG_04746,FUN_022627-T1,Peve_00012280,Pocillopora_meandrina_HIv1___RNAseq.g4385.t1,three_way,74.43166666666667,FUN_022627-T1,Q13485,SMAD4_HUMAN,,Mothers against decapentaplegic homolog 4 (MAD homolog 4) (Mothers against DPP homolog 4) (Deletion target in pancreatic carcinoma 4) (SMAD family member 4) (SMAD 4) (Smad4) (hSMAD4),Homo sapiens (Human),52.7,220.0,2.4e-51,205.7,sp|Q13485|SMAD4_HUMAN Mothers against decapentaplegic homolog 4 OS=Homo sapiens OX=9606 GN=SMAD4 PE=1 SV=1,GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001222; GO:0001223; GO:0001228; GO:0001541; GO:0001649; GO:0001658; GO:0001666; GO:0001701; GO:0001702; GO:0001837; GO:0003148; GO:0003161; GO:0003190; GO:0003198; GO:0003220; GO:0003251; GO:0003360; GO:0003682; GO:0003700; GO:0005518; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005813; GO:0005829; GO:0006351; GO:0006355; GO:0006357; GO:0006366; GO:0006879; GO:0007179; GO:0007283; GO:0007338; GO:0007411; GO:0008283; GO:0008285; GO:0009653; GO:0010614; GO:0010628; GO:0010631; GO:0010666; GO:0010718; GO:0014033; GO:0014898; GO:0030154; GO:0030308; GO:0030325; GO:0030509; GO:0030511; GO:0031005; GO:0032444; GO:0032525; GO:0032909; GO:0032924; GO:0033686; GO:0035556; GO:0036064; GO:0036302; GO:0042118; GO:0042177; GO:0042733; GO:0042802; GO:0042803; GO:0043199; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0046881; GO:0048382; GO:0048589; GO:0048665; GO:0048733; GO:0048859; GO:0051797; GO:0060065; GO:0060391; GO:0060395; GO:0060412; GO:0060956; GO:0061040; GO:0061629; GO:0062009; GO:0070102; GO:0070371; GO:0070373; GO:0070411; GO:0070412; GO:0071141; GO:0071144; GO:0071333; GO:0071559; GO:0071560; GO:0071773; GO:0072133; GO:0072134; GO:0072520; GO:0090090; GO:0097191; GO:1901203; GO:1902895; GO:1905305,activin receptor signaling pathway [GO:0032924]; adrenal gland development [GO:0030325]; anatomical structure morphogenesis [GO:0009653]; atrioventricular canal development [GO:0036302]; atrioventricular valve formation [GO:0003190]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; brainstem development [GO:0003360]; branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac conduction system development [GO:0003161]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cellular response to BMP stimulus [GO:0071773]; cellular response to glucose stimulus [GO:0071333]; cellular response to transforming growth factor beta stimulus [GO:0071560]; developmental growth [GO:0048589]; DNA-templated transcription [GO:0006351]; embryonic digit morphogenesis [GO:0042733]; endocardial cell differentiation [GO:0060956]; endothelial cell activation [GO:0042118]; epithelial cell migration [GO:0010631]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; ERK1 and ERK2 cascade [GO:0070371]; extrinsic apoptotic signaling pathway [GO:0097191]; female gonad morphogenesis [GO:0061040]; formation of anatomical boundary [GO:0048859]; gastrulation with mouth forming second [GO:0001702]; in utero embryonic development [GO:0001701]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular iron ion homeostasis [GO:0006879]; intracellular signal transduction [GO:0035556]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; mesendoderm development [GO:0048382]; metanephric mesenchyme morphogenesis [GO:0072133]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cardiac myofibril assembly [GO:1905305]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural crest cell differentiation [GO:0014033]; neuron fate specification [GO:0048665]; osteoblast differentiation [GO:0001649]; outflow tract septum morphogenesis [GO:0003148]; ovarian follicle development [GO:0001541]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell proliferation involved in heart valve morphogenesis [GO:0003251]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of gene expression [GO:0010628]; positive regulation of luteinizing hormone secretion [GO:0033686]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of DNA-templated transcription [GO:0006355]; regulation of hair follicle development [GO:0051797]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transforming growth factor beta2 production [GO:0032909]; response to hypoxia [GO:0001666]; response to transforming growth factor beta [GO:0071559]; sebaceous gland development [GO:0048733]; secondary palate development [GO:0062009]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; SMAD protein signal transduction [GO:0060395]; somite rostral/caudal axis specification [GO:0032525]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]; ventricular septum morphogenesis [GO:0060412],activin responsive factor complex [GO:0032444]; centrosome [GO:0005813]; chromatin [GO:0000785]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMAD protein complex [GO:0071141]; transcription regulator complex [GO:0005667],"chromatin binding [GO:0003682]; collagen binding [GO:0005518]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; filamin binding [GO:0031005]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; R-SMAD binding [GO:0070412]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sulfate binding [GO:0043199]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; transcription corepressor binding [GO:0001222]",GO:0003012; GO:0003677; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0006351; GO:0006355; GO:0008092; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0140110,muscle system process; DNA binding; nucleus; nucleoplasm; microtubule organizing center; cytosol; DNA-templated transcription; regulation of DNA-templated transcription; cytoskeletal protein binding; reproductive process; cell differentiation; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_06181,0.395806804934849,OG_06181,FUN_028088-T1,Peve_00031660,Pocillopora_meandrina_HIv1___TS.g11574.t1,three_way,88.21483333333333,FUN_028088-T1,P18907,,,,,76.6,988.0,0.0,1502.3,sp|P18907|AT1A1_HORSE Sodium/potassium-transporting ATPase subunit alpha-1 OS=Equus caballus OX=9796 GN=ATP1A1 PE=3 SV=1,,,,,,
OG_00213,0.393792660137693,OG_00213,FUN_000932-T1,Peve_00009724,Pocillopora_meandrina_HIv1___RNAseq.g29460.t1,three_way,85.761,FUN_000932-T1,P00516,,,,,65.8,619.0,1.3e-240,833.9,sp|P00516|KGP1_BOVIN cGMP-dependent protein kinase 1 OS=Bos taurus OX=9913 GN=PRKG1 PE=1 SV=2,,,,,,
OG_01532,0.3937163719305493,OG_01532,FUN_006331-T1,Peve_00012580,Pocillopora_meandrina_HIv1___RNAseq.g20347.t1,three_way,69.86616666666667,FUN_006331-T1,Q92545,TM131_HUMAN,,Transmembrane protein 131 (Protein RW1),Homo sapiens (Human),41.2,1098.0,1.3000000000000002e-218,762.3,sp|Q92545|TM131_HUMAN Transmembrane protein 131 OS=Homo sapiens OX=9606 GN=TMEM131 PE=1 SV=3,GO:0005518; GO:0016020; GO:0032964,collagen biosynthetic process [GO:0032964],membrane [GO:0016020],collagen binding [GO:0005518],,
OG_06592,0.3921043004306556,OG_06592,FUN_029640-T1,Peve_00037895,Pocillopora_meandrina_HIv1___RNAseq.g17204.t1,three_way,61.37616666666666,FUN_029640-T1,A2ARV4,LRP2_MOUSE,,Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin),Mus musculus (Mouse),38.1,428.0,4.3e-50,201.4,sp|A2ARV4|LRP2_MOUSE Low-density lipoprotein receptor-related protein 2 OS=Mus musculus OX=10090 GN=Lrp2 PE=1 SV=1,GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003151; GO:0003223; GO:0003281; GO:0005509; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005903; GO:0005905; GO:0006898; GO:0007507; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0010467; GO:0015031; GO:0016020; GO:0016324; GO:0017124; GO:0030001; GO:0030139; GO:0030424; GO:0030425; GO:0030514; GO:0030900; GO:0031526; GO:0031904; GO:0034311; GO:0035904; GO:0042359; GO:0043066; GO:0043235; GO:0043491; GO:0044321; GO:0045177; GO:0050769; GO:0051087; GO:0060068; GO:0060976; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1904888,aorta development [GO:0035904]; cell population proliferation [GO:0008283]; coronary artery morphogenesis [GO:0060982]; coronary vasculature development [GO:0060976]; cranial skeletal system development [GO:1904888]; diol metabolic process [GO:0034311]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; gene expression [GO:0010467]; heart development [GO:0007507]; kidney development [GO:0001822]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359],apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124],GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0006629; GO:0016192; GO:0022414; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0055085,endosome; endoplasmic reticulum; Golgi apparatus; plasma membrane; lipid metabolic process; vesicle-mediated transport; reproductive process; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; transmembrane transport
OG_09605,0.3911615065533916,OG_09605,FUN_041759-T1,Peve_00041567,Pocillopora_meandrina_HIv1___RNAseq.g15102.t1,three_way,88.23033333333333,FUN_041759-T1,Q7XMK8,,,,,72.9,402.0,1.1e-173,610.9,sp|Q7XMK8|RH6_ORYSJ DEAD-box ATP-dependent RNA helicase 6 OS=Oryza sativa subsp. japonica OX=39947 GN=Os04g0533000 PE=2 SV=1,,,,,,
OG_08594,0.3908659244803555,OG_08594,FUN_037709-T1,Peve_00027437,Pocillopora_meandrina_HIv1___RNAseq.g1402.t1,three_way,58.09033333333333,FUN_037709-T1,E7F1U2,DNMBP_DANRE,,Dynamin-binding protein (Scaffold protein Tuba),Danio rerio (Zebrafish) (Brachydanio rerio),32.4,728.0,7.8e-103,377.5,sp|E7F1U2|DNMBP_DANRE Dynamin-binding protein OS=Danio rerio OX=7955 GN=dnmbp PE=2 SV=1,GO:0001822; GO:0005085; GO:0005737; GO:0005794; GO:0005795; GO:0005856; GO:0005911; GO:0035556; GO:0045202; GO:0060271; GO:0098793,cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822],cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; presynapse [GO:0098793]; synapse [GO:0045202],guanyl-nucleotide exchange factor activity [GO:0005085],GO:0005794; GO:0005856; GO:0043226; GO:0044782; GO:0048856; GO:0098772,Golgi apparatus; cytoskeleton; organelle; cilium organization; anatomical structure development; molecular function regulator activity
OG_09811,0.3899186835722406,OG_09811,FUN_042633-T1,Peve_00030033,Pocillopora_meandrina_HIv1___RNAseq.19516_t,three_way,82.042,FUN_042633-T1,P08651,NFIC_HUMAN,,Nuclear factor 1 C-type (NF1-C) (Nuclear factor 1/C) (CCAAT-box-binding transcription factor) (CTF) (Nuclear factor I/C) (NF-I/C) (NFI-C) (TGGCA-binding protein),Homo sapiens (Human),48.2,390.0,3.2e-79,297.7,sp|P08651|NFIC_HUMAN Nuclear factor 1 C-type OS=Homo sapiens OX=9606 GN=NFIC PE=1 SV=2,GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001650; GO:0003700; GO:0005634; GO:0005654; GO:0006260; GO:0006357; GO:0006366; GO:0042475; GO:0045944; GO:1990837,DNA replication [GO:0006260]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366],chromatin [GO:0000785]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0006260; GO:0006351; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; DNA replication; DNA-templated transcription; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_06281,0.3895532754815927,OG_06281,FUN_028450-T1,Peve_00002378,Pocillopora_meandrina_HIv1___RNAseq.g16191.t1,three_way,41.13883333333333,FUN_028450-T1,A4IGL7,PXDN_XENTR,,Peroxidasin (EC 1.11.2.-) [Cleaved into: PXDN active fragment],Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),28.0,168.0,1.3e-08,62.8,sp|A4IGL7|PXDN_XENTR Peroxidasin OS=Xenopus tropicalis OX=8364 GN=pxdn PE=2 SV=1,GO:0001525; GO:0005576; GO:0005604; GO:0005783; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0031012; GO:0042744; GO:0046872; GO:0051260; GO:0070207; GO:0070831; GO:0071711; GO:0140825,angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; hydrogen peroxide catabolic process [GO:0042744]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979],basement membrane [GO:0005604]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576],"heme binding [GO:0020037]; lactoperoxidase activity [GO:0140825]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]",GO:0003824; GO:0005576; GO:0005783; GO:0007155; GO:0016209; GO:0016491; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0065003,catalytic activity; extracellular region; endoplasmic reticulum; cell adhesion; antioxidant activity; oxidoreductase activity; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; protein-containing complex assembly
OG_04542,0.3892453073886436,OG_04542,FUN_022103-T1,Peve_00009716,Pocillopora_meandrina_HIv1___RNAseq.g4105.t1,three_way,85.40766666666667,FUN_022103-T1,A6H779,FBXL2_BOVIN,,F-box/LRR-repeat protein 2 (F-box and leucine-rich repeat protein 2),Bos taurus (Bovine),69.6,102.0,2.1e-37,158.3,sp|A6H779|FBXL2_BOVIN F-box/LRR-repeat protein 2 OS=Bos taurus OX=9913 GN=FBXL2 PE=2 SV=1,GO:0005516; GO:0006513; GO:0010506; GO:0016020; GO:0016567; GO:0019005; GO:0019903; GO:0031146; GO:0036312; GO:0044830; GO:0050727; GO:0051896; GO:1900226; GO:1990756,modulation by host of viral RNA genome replication [GO:0044830]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; regulation of inflammatory response [GO:0050727]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],membrane [GO:0016020]; SCF ubiquitin ligase complex [GO:0019005],calmodulin binding [GO:0005516]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein phosphatase binding [GO:0019903]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0030163; GO:0060090,protein catabolic process; molecular adaptor activity
OG_01906,0.3890509254722917,OG_01906,FUN_007920-T1,Peve_00040676,Pocillopora_meandrina_HIv1___RNAseq.g30096.t1,three_way,80.76266666666666,FUN_007920-T1,Q96L93,KI16B_HUMAN,,Kinesin-like protein KIF16B (Sorting nexin-23),Homo sapiens (Human),61.6,620.0,3.3e-199,697.6,sp|Q96L93|KI16B_HUMAN Kinesin-like protein KIF16B OS=Homo sapiens OX=9606 GN=KIF16B PE=1 SV=2,GO:0001704; GO:0001919; GO:0005524; GO:0005547; GO:0005737; GO:0005768; GO:0005769; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0047496; GO:0080025,early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]; vesicle transport along microtubule [GO:0047496],cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819],"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; plus-end-directed microtubule motor activity [GO:0008574]",GO:0003774; GO:0003824; GO:0005768; GO:0005829; GO:0007018; GO:0008092; GO:0008289; GO:0016192; GO:0016787; GO:0016853; GO:0031410; GO:0043226; GO:0048856; GO:0140657,cytoskeletal motor activity; catalytic activity; endosome; cytosol; microtubule-based movement; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; hydrolase activity; isomerase activity; cytoplasmic vesicle; organelle; anatomical structure development; ATP-dependent activity
OG_01906,0.3890509254722917,OG_01906,FUN_007920-T1,Peve_00040676,Pocillopora_meandrina_HIv1___RNAseq.g30096.t1,three_way,80.76266666666666,FUN_007920-T1,Q96L93,KI16B_HUMAN,,Kinesin-like protein KIF16B (Sorting nexin-23),Homo sapiens (Human),40.4,146.0,3.1999999999999997e-29,132.9,sp|Q96L93|KI16B_HUMAN Kinesin-like protein KIF16B OS=Homo sapiens OX=9606 GN=KIF16B PE=1 SV=2,GO:0001704; GO:0001919; GO:0005524; GO:0005547; GO:0005737; GO:0005768; GO:0005769; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0047496; GO:0080025,early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]; vesicle transport along microtubule [GO:0047496],cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819],"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; plus-end-directed microtubule motor activity [GO:0008574]",GO:0003774; GO:0003824; GO:0005768; GO:0005829; GO:0007018; GO:0008092; GO:0008289; GO:0016192; GO:0016787; GO:0016853; GO:0031410; GO:0043226; GO:0048856; GO:0140657,cytoskeletal motor activity; catalytic activity; endosome; cytosol; microtubule-based movement; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; hydrolase activity; isomerase activity; cytoplasmic vesicle; organelle; anatomical structure development; ATP-dependent activity
OG_03957,0.3878163213993525,OG_03957,FUN_016102-T1,Peve_00010769,Pocillopora_meandrina_HIv1___RNAseq.g21592.t1,three_way,72.49366666666667,FUN_016102-T1,Q62985,SH2B1_RAT,,SH2B adapter protein 1 (FceRI gamma-chain-interacting protein SH2-B) (SH2 domain-containing protein 1B) (SH2-B PH domain-containing signaling mediator 1),Rattus norvegicus (Rat),39.9,358.0,1.1e-52,209.5,sp|Q62985|SH2B1_RAT SH2B adapter protein 1 OS=Rattus norvegicus OX=10116 GN=Sh2b1 PE=1 SV=1,GO:0005068; GO:0005634; GO:0005737; GO:0005886; GO:0030032; GO:0035556; GO:0045840; GO:0048870; GO:0060391; GO:2000278,cell motility [GO:0048870]; intracellular signal transduction [GO:0035556]; lamellipodium assembly [GO:0030032]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of SMAD protein signal transduction [GO:0060391]; regulation of DNA biosynthetic process [GO:2000278],cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886],transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068],GO:0005634; GO:0005886; GO:0043226; GO:0048870; GO:0060090,nucleus; plasma membrane; organelle; cell motility; molecular adaptor activity
OG_09247,0.3875120983111484,OG_09247,FUN_040037-T1,Peve_00040431,Pocillopora_meandrina_HIv1___RNAseq.g8456.t1,three_way,47.013000000000005,FUN_040037-T1,P02788,TRFL_HUMAN,,Lactotransferrin (Lactoferrin) (EC 3.4.21.-) (Growth-inhibiting protein 12) (Talalactoferrin) [Cleaved into: Lactoferricin-H (Lfcin-H); Kaliocin-1; Lactoferroxin-A; Lactoferroxin-B; Lactoferroxin-C],Homo sapiens (Human),26.8,567.0,3.6e-34,149.1,sp|P02788|TRFL_HUMAN Lactotransferrin OS=Homo sapiens OX=9606 GN=LTF PE=1 SV=6,GO:0001503; GO:0001530; GO:0001817; GO:0002227; GO:0003677; GO:0004252; GO:0004869; GO:0005506; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005769; GO:0005886; GO:0006508; GO:0006826; GO:0006959; GO:0008201; GO:0009986; GO:0019731; GO:0019732; GO:0030141; GO:0031640; GO:0031665; GO:0032680; GO:0032780; GO:0032991; GO:0033690; GO:0034145; GO:0035580; GO:0042581; GO:0043066; GO:0043123; GO:0043539; GO:0044793; GO:0045071; GO:0045669; GO:0048525; GO:0050829; GO:0051092; GO:0055037; GO:0060349; GO:0061844; GO:0070062; GO:0071902; GO:0097013; GO:0140912; GO:1900159; GO:1900229; GO:1902732; GO:1904724; GO:2000308; GO:2001205,antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; bone morphogenesis [GO:0060349]; defense response to Gram-negative bacterium [GO:0050829]; humoral immune response [GO:0006959]; innate immune response in mucosa [GO:0002227]; iron ion transport [GO:0006826]; killing of cells of another organism [GO:0031640]; negative regulation by host of viral process [GO:0044793]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of osteoclast development [GO:2001205]; negative regulation of single-species biofilm formation in or on host organism [GO:1900229]; negative regulation of tumor necrosis factor (ligand) superfamily member 11 production [GO:2000308]; negative regulation of viral genome replication [GO:0045071]; negative regulation of viral process [GO:0048525]; ossification [GO:0001503]; positive regulation of bone mineralization involved in bone maturation [GO:1900159]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; proteolysis [GO:0006508]; regulation of cytokine production [GO:0001817]; regulation of tumor necrosis factor production [GO:0032680],cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; phagocytic vesicle lumen [GO:0097013]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; secretory granule [GO:0030141]; specific granule [GO:0042581]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724],cysteine-type endopeptidase inhibitor activity [GO:0004869]; DNA binding [GO:0003677]; heparin binding [GO:0008201]; iron ion binding [GO:0005506]; lipopolysaccharide binding [GO:0001530]; membrane destabilizing activity [GO:0140912]; protein serine/threonine kinase activator activity [GO:0043539]; serine-type endopeptidase activity [GO:0004252],GO:0002376; GO:0003677; GO:0003824; GO:0005576; GO:0005615; GO:0005634; GO:0005768; GO:0005886; GO:0006355; GO:0008289; GO:0016787; GO:0031410; GO:0043226; GO:0098542; GO:0098772; GO:0140096,"immune system process; DNA binding; catalytic activity; extracellular region; extracellular space; nucleus; endosome; plasma membrane; regulation of DNA-templated transcription; lipid binding; hydrolase activity; cytoplasmic vesicle; organelle; defense response to other organism; molecular function regulator activity; catalytic activity, acting on a protein"
OG_08842,0.3872477739759213,OG_08842,FUN_038187-T1,Peve_00006347,Pocillopora_meandrina_HIv1___RNAseq.g945.t1,three_way,61.87833333333334,FUN_038187-T1,Q80ZA4,PKHL1_MOUSE,,Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) (Protein D86),Mus musculus (Mouse),34.3,4297.0,0.0,2329.7,sp|Q80ZA4|PKHL1_MOUSE Fibrocystin-L OS=Mus musculus OX=10090 GN=Pkhd1l1 PE=1 SV=1,GO:0007605; GO:0032426; GO:0060171; GO:0120234,sensory perception of sound [GO:0007605],stereocilium coat [GO:0120234]; stereocilium membrane [GO:0060171]; stereocilium tip [GO:0032426],,GO:0030312; GO:0050877,external encapsulating structure; nervous system process
OG_05287,0.3870962661625374,OG_05287,FUN_023950-T1,Peve_00017994,Pocillopora_meandrina_HIv1___RNAseq.g18524.t1a,three_way,76.55283333333334,FUN_023950-T1,Q92793,CBP_HUMAN,,CREB-binding protein (Histone lysine acetyltransferase CREBBP) (EC 2.3.1.48) (Protein lactyltransferas CREBBP) (EC 2.3.1.-) (Protein-lysine acetyltransferase CREBBP) (EC 2.3.1.-),Homo sapiens (Human),41.9,2186.0,0.0,1193.7,sp|Q92793|CBP_HUMAN CREB-binding protein OS=Homo sapiens OX=9606 GN=CREBBP PE=1 SV=3,GO:0000122; GO:0000123; GO:0000785; GO:0001223; GO:0001666; GO:0002039; GO:0002223; GO:0003682; GO:0003684; GO:0003713; GO:0003714; GO:0004402; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006355; GO:0006473; GO:0007165; GO:0007249; GO:0008270; GO:0008589; GO:0016407; GO:0016479; GO:0016604; GO:0018076; GO:0030511; GO:0031490; GO:0031648; GO:0031669; GO:0034644; GO:0042592; GO:0042733; GO:0043426; GO:0043993; GO:0044017; GO:0045893; GO:0045944; GO:0048156; GO:0048511; GO:0061629; GO:0061733; GO:0065003; GO:0120300; GO:0140297; GO:1900034; GO:1900182; GO:1905168,canonical NF-kappaB signal transduction [GO:0007249]; cellular response to nutrient levels [GO:0031669]; cellular response to UV [GO:0034644]; embryonic digit morphogenesis [GO:0042733]; homeostatic process [GO:0042592]; N-terminal peptidyl-lysine acetylation [GO:0018076]; negative regulation of transcription by RNA polymerase I [GO:0016479]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein acetylation [GO:0006473]; protein destabilization [GO:0031648]; protein-containing complex assembly [GO:0065003]; regulation of cellular response to heat [GO:1900034]; regulation of DNA-templated transcription [GO:0006355]; regulation of smoothened signaling pathway [GO:0008589]; response to hypoxia [GO:0001666]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223],chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],acetyltransferase activity [GO:0016407]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; damaged DNA binding [GO:0003684]; DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase activity [GO:0004402]; histone H3K18 acetyltransferase activity [GO:0043993]; histone H3K27 acetyltransferase activity [GO:0044017]; MRF binding [GO:0043426]; p53 binding [GO:0002039]; peptide lactyltransferase (CoA-dependent) activity [GO:0120300]; protein-lysine-acetyltransferase activity [GO:0061733]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; tau protein binding [GO:0048156]; transcription coactivator activity [GO:0003713]; transcription coactivator binding [GO:0001223]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0008092; GO:0016740; GO:0043226; GO:0051604; GO:0060090; GO:0065003; GO:0140096; GO:0140110,"immune system process; DNA binding; catalytic activity; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; cytoskeletal protein binding; transferase activity; organelle; protein maturation; molecular adaptor activity; protein-containing complex assembly; catalytic activity, acting on a protein; transcription regulator activity"
OG_04032,0.386793509652522,OG_04032,FUN_016340-T1,Peve_00044576,Pocillopora_meandrina_HIv1___RNAseq.g9730.t1,three_way,73.72266666666667,FUN_016340-T1,Q6P7A2,UBE4A_RAT,,Ubiquitin conjugation factor E4 A (EC 2.3.2.27) (RING-type E3 ubiquitin transferase E4 A),Rattus norvegicus (Rat),39.6,1095.0,2.2e-194,681.0,sp|Q6P7A2|UBE4A_RAT Ubiquitin conjugation factor E4 A OS=Rattus norvegicus OX=10116 GN=Ube4a PE=2 SV=1,GO:0000151; GO:0000209; GO:0005634; GO:0005737; GO:0006511; GO:0034450; GO:0036503; GO:0061630,ERAD pathway [GO:0036503]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450],GO:0003824; GO:0005634; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_06961,0.3867347322463446,OG_06961,FUN_032091-T1,Peve_00012819,Pocillopora_meandrina_HIv1___RNAseq.g5277.t1,three_way,71.29066666666667,FUN_032091-T1,Q00IB7,,,,,40.9,952.0,1.5e-190,668.7,sp|Q00IB7|PKHH1_DANRE Pleckstrin homology domain-containing family H member 1 OS=Danio rerio OX=7955 GN=plekhh1 PE=2 SV=1,,,,,,
OG_10051,0.3866147070883992,OG_10051,FUN_043325-T1,Peve_00043035,Pocillopora_meandrina_HIv1___RNAseq.g8952.t1,three_way,72.11733333333333,FUN_043325-T1,Q2HWF0,FBP1L_RAT,,Formin-binding protein 1-like (Transducer of Cdc42-dependent actin assembly protein 1) (Toca-1),Rattus norvegicus (Rat),31.6,604.0,1.9000000000000002e-74,281.6,sp|Q2HWF0|FBP1L_RAT Formin-binding protein 1-like OS=Rattus norvegicus OX=10116 GN=Fnbp1l PE=1 SV=2,GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0006900; GO:0006914; GO:0007165; GO:0007399; GO:0008289; GO:0010324; GO:0016050; GO:0030050; GO:0030154; GO:0031410; GO:0051020; GO:0051491; GO:0060271; GO:0072583; GO:0097320,autophagy [GO:0006914]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; nervous system development [GO:0007399]; plasma membrane tubulation [GO:0097320]; positive regulation of filopodium assembly [GO:0051491]; signal transduction [GO:0007165]; vesicle budding from membrane [GO:0006900]; vesicle organization [GO:0016050]; vesicle transport along actin filament [GO:0030050],cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886],GTPase binding [GO:0051020]; lipid binding [GO:0008289],GO:0005829; GO:0005856; GO:0005886; GO:0006914; GO:0008289; GO:0016192; GO:0030154; GO:0031410; GO:0043226; GO:0044782; GO:0048856; GO:0061024,cytosol; cytoskeleton; plasma membrane; autophagy; lipid binding; vesicle-mediated transport; cell differentiation; cytoplasmic vesicle; organelle; cilium organization; anatomical structure development; membrane organization
OG_01584,0.3860886649658558,OG_01584,FUN_006621-T1,Peve_00040867,Pocillopora_meandrina_HIv1___RNAseq.g20504.t1,three_way,51.0425,FUN_006621-T1,Q8WWI1,LMO7_HUMAN,,LIM domain only protein 7 (LMO-7) (F-box only protein 20) (LOMP),Homo sapiens (Human),43.5,131.0,4.7e-23,112.8,sp|Q8WWI1|LMO7_HUMAN LIM domain only protein 7 OS=Homo sapiens OX=9606 GN=LMO7 PE=1 SV=3,GO:0000151; GO:0004842; GO:0005634; GO:0005635; GO:0005737; GO:0005739; GO:0005829; GO:0005925; GO:0009986; GO:0016324; GO:0016567; GO:0023051; GO:0030155; GO:0045944; GO:0046872,positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; regulation of cell adhesion [GO:0030155]; regulation of signaling [GO:0023051],apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0005634; GO:0005635; GO:0005739; GO:0005829; GO:0006355; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; nuclear envelope; mitochondrion; cytosol; regulation of DNA-templated transcription; transferase activity; organelle; catalytic activity, acting on a protein"
OG_02516,0.3858568813970299,OG_02516,FUN_010575-T1,Peve_00032734,Pocillopora_meandrina_HIv1___RNAseq.g21523.t1,three_way,73.19066666666667,FUN_010575-T1,Q9C091,GRB1L_HUMAN,,GREB1-like protein (Growth regulation by estrogen in breast cancer 1-like protein),Homo sapiens (Human),33.4,1940.0,6.8e-250,866.3,sp|Q9C091|GRB1L_HUMAN GREB1-like protein OS=Homo sapiens OX=9606 GN=GREB1L PE=1 SV=2,GO:0001656; GO:0001658; GO:0001822; GO:0002009; GO:0003151; GO:0003231; GO:0016020; GO:0030539; GO:0035050; GO:0042254; GO:0048384; GO:0055007; GO:0060065; GO:0061205; GO:0072177,branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac muscle cell differentiation [GO:0055007]; cardiac ventricle development [GO:0003231]; embryonic heart tube development [GO:0035050]; kidney development [GO:0001822]; male genitalia development [GO:0030539]; mesonephric duct development [GO:0072177]; metanephros development [GO:0001656]; morphogenesis of an epithelium [GO:0002009]; outflow tract morphogenesis [GO:0003151]; paramesonephric duct development [GO:0061205]; retinoic acid receptor signaling pathway [GO:0048384]; ribosome biogenesis [GO:0042254]; uterus development [GO:0060065],membrane [GO:0016020],,GO:0022414; GO:0030154; GO:0042254; GO:0048856,reproductive process; cell differentiation; ribosome biogenesis; anatomical structure development
OG_07674,0.385783789593092,OG_07674,FUN_034781-T1,Peve_00029730,Pocillopora_meandrina_HIv1___RNAseq.g12276.t1,three_way,58.02466666666667,FUN_034781-T1,Q6DIJ4,UBP10_XENTR,,Ubiquitin carboxyl-terminal hydrolase 10 (EC 3.4.19.12) (Deubiquitinating enzyme 10) (Ubiquitin thioesterase 10) (Ubiquitin-specific-processing protease 10),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),43.1,485.0,6.800000000000001e-100,366.7,sp|Q6DIJ4|UBP10_XENTR Ubiquitin carboxyl-terminal hydrolase 10 OS=Xenopus tropicalis OX=8364 GN=usp10 PE=2 SV=1,GO:0002039; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005769; GO:0006281; GO:0006508; GO:0006914; GO:0006974; GO:0010506; GO:0016579; GO:0030330; GO:0043124; GO:0044325; GO:0062030; GO:0071347; GO:0072344,"autophagy [GO:0006914]; cellular response to interleukin-1 [GO:0071347]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA repair [GO:0006281]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of stress granule assembly [GO:0062030]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation of autophagy [GO:0010506]; rescue of stalled ribosome [GO:0072344]",cytoplasm [GO:0005737]; early endosome [GO:0005769]; nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; p53 binding [GO:0002039]; transmembrane transporter binding [GO:0044325],GO:0003824; GO:0005634; GO:0005768; GO:0006281; GO:0006914; GO:0016787; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; nucleus; endosome; DNA repair; autophagy; hydrolase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_02562,0.3855382157089561,OG_02562,FUN_010661-T1,Peve_00031438,Pocillopora_meandrina_HIv1___RNAseq.g21311.t1,three_way,73.56683333333334,FUN_010661-T1,O43491,E41L2_HUMAN,,Band 4.1-like protein 2 (Erythrocyte membrane protein band 4.1-like 2) (Generally expressed protein 4.1) (4.1G),Homo sapiens (Human),49.4,336.0,2.6e-87,325.1,sp|O43491|E41L2_HUMAN Band 4.1-like protein 2 OS=Homo sapiens OX=9606 GN=EPB41L2 PE=1 SV=1,GO:0003779; GO:0005198; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0005938; GO:0008091; GO:0030054; GO:0030507; GO:0030866; GO:0031032; GO:0042731; GO:0051301; GO:0070062; GO:1904778,actomyosin structure organization [GO:0031032]; cell division [GO:0051301]; cortical actin cytoskeleton organization [GO:0030866]; positive regulation of protein localization to cell cortex [GO:1904778],cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; spectrin [GO:0008091],actin binding [GO:0003779]; PH domain binding [GO:0042731]; spectrin binding [GO:0030507]; structural molecule activity [GO:0005198],GO:0005198; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0008092; GO:0043226,structural molecule activity; nucleoplasm; cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_02683,0.3854627870322012,OG_02683,FUN_010941-T1,Peve_00005967,Pocillopora_meandrina_HIv1___RNAseq.g21806.t1,three_way,91.54933333333334,FUN_010941-T1,E2QWQ2,NLK_CANLF,,Serine/threonine-protein kinase NLK (EC 2.7.11.24) (Nemo-like kinase),Canis lupus familiaris (Dog) (Canis familiaris),72.8,390.0,1.6000000000000002e-164,580.5,sp|E2QWQ2|NLK_CANLF Serine/threonine-protein kinase NLK OS=Canis lupus familiaris OX=9615 GN=NLK PE=3 SV=1,GO:0000287; GO:0004674; GO:0004707; GO:0005524; GO:0005634; GO:0005737; GO:0006355; GO:0007179; GO:0016055; GO:0030178; GO:0031625; GO:0035556; GO:0042169; GO:0050821; GO:0071470; GO:0106310; GO:0140297; GO:1904262; GO:1904894,cellular response to osmotic stress [GO:0071470]; intracellular signal transduction [GO:0035556]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; protein stabilization [GO:0050821]; regulation of DNA-templated transcription [GO:0006355]; transforming growth factor beta receptor signaling pathway [GO:0007179]; Wnt signaling pathway [GO:0016055],cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; DNA-binding transcription factor binding [GO:0140297]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; SH2 domain binding [GO:0042169]; ubiquitin protein ligase binding [GO:0031625],GO:0003824; GO:0005634; GO:0006355; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; regulation of DNA-templated transcription; transferase activity; organelle; catalytic activity, acting on a protein"
OG_01954,0.3843782905038624,OG_01954,FUN_008020-T1,Peve_00031302,Pocillopora_meandrina_HIv1___RNAseq.g30341.t1,three_way,85.20216666666667,FUN_008020-T1,P27448,MARK3_HUMAN,,MAP/microtubule affinity-regulating kinase 3 (EC 2.7.11.1) (C-TAK1) (cTAK1) (Cdc25C-associated protein kinase 1) (ELKL motif kinase 2) (EMK-2) (Protein kinase STK10) (Ser/Thr protein kinase PAR-1) (Par-1a) (Serine/threonine-protein kinase p78),Homo sapiens (Human),52.2,826.0,3.2000000000000005e-201,703.4,sp|P27448|MARK3_HUMAN MAP/microtubule affinity-regulating kinase 3 OS=Homo sapiens OX=9606 GN=MARK3 PE=1 SV=5,GO:0000226; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0010389; GO:0019903; GO:0030425; GO:0035331; GO:0035556; GO:0048156; GO:0050321; GO:0070062; GO:0106310; GO:1900181,intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of hippo signaling [GO:0035331]; negative regulation of protein localization to nucleus [GO:1900181]; protein phosphorylation [GO:0006468]; regulation of G2/M transition of mitotic cell cycle [GO:0010389],cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321],GO:0003824; GO:0005829; GO:0005886; GO:0007010; GO:0008092; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; cytosol; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; transferase activity; organelle; catalytic activity, acting on a protein"
OG_09598,0.3837539447875412,OG_09598,FUN_041745-T1,Peve_00000338,Pocillopora_meandrina_HIv1___RNAseq.g15790.t1,three_way,56.4945,,,,,,,,,,,,,,,,,
OG_01447,0.3836116844051033,OG_01447,FUN_005896-T1,Peve_00035817,Pocillopora_meandrina_HIv1___RNAseq.3177_t,three_way,67.3925,FUN_005896-T1,Q8K2Y0,,,,,39.0,141.0,1.2e-15,86.3,sp|Q8K2Y0|OBI1_MOUSE ORC ubiquitin ligase 1 OS=Mus musculus OX=10090 GN=Obi1 PE=1 SV=2,,,,,,
OG_03209,0.383203719550061,OG_03209,FUN_012701-T1,Peve_00016835,Pocillopora_meandrina_HIv1___RNAseq.g12828.t1,three_way,66.00966666666667,,,,,,,,,,,,,,,,,
OG_09830,0.3831663921207868,OG_09830,FUN_042807-T1,Peve_00003076,Pocillopora_meandrina_HIv1___RNAseq.g7424.t1,three_way,78.86633333333333,FUN_042807-T1,P41240,CSK_HUMAN,,Tyrosine-protein kinase CSK (EC 2.7.10.2) (C-Src kinase) (Protein-tyrosine kinase CYL),Homo sapiens (Human),56.1,442.0,8.4e-143,508.4,sp|P41240|CSK_HUMAN Tyrosine-protein kinase CSK OS=Homo sapiens OX=9606 GN=CSK PE=1 SV=1,GO:0002250; GO:0004713; GO:0004715; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0008285; GO:0010989; GO:0019903; GO:0031295; GO:0032715; GO:0034236; GO:0034332; GO:0035556; GO:0042802; GO:0042997; GO:0045779; GO:0046872; GO:0048709; GO:0050765; GO:0050852; GO:0050860; GO:0050868; GO:0060368; GO:0070062; GO:0070064; GO:0070373; GO:0071375; GO:1990782,adaptive immune response [GO:0002250]; adherens junction organization [GO:0034332]; cellular response to peptide hormone stimulus [GO:0071375]; intracellular signal transduction [GO:0035556]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of phagocytosis [GO:0050765]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; oligodendrocyte differentiation [GO:0048709]; protein phosphorylation [GO:0006468]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852],cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; proline-rich region binding [GO:0070064]; protein kinase A catalytic subunit binding [GO:0034236]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; protein tyrosine kinase binding [GO:1990782],GO:0002376; GO:0003824; GO:0005829; GO:0005886; GO:0016740; GO:0030154; GO:0034330; GO:0043226; GO:0140096,"immune system process; catalytic activity; cytosol; plasma membrane; transferase activity; cell differentiation; cell junction organization; organelle; catalytic activity, acting on a protein"
OG_02940,0.3826093823608974,OG_02940,FUN_012049-T1,Peve_00004088,Pocillopora_meandrina_HIv1___RNAseq.g23650.t3,three_way,68.88266666666667,FUN_012049-T1,E7EZG2,MY9AA_DANRE,,Unconventional myosin-IXAa (Myosin IXAa),Danio rerio (Zebrafish) (Brachydanio rerio),33.3,2215.0,4.1e-257,890.2,sp|E7EZG2|MY9AA_DANRE Unconventional myosin-IXAa OS=Danio rerio OX=7955 GN=myo9aa PE=3 SV=1,GO:0000146; GO:0005096; GO:0005524; GO:0005737; GO:0005884; GO:0007626; GO:0008270; GO:0016020; GO:0016459; GO:0035556; GO:0036269; GO:0044295; GO:0045198; GO:0045202; GO:0048675; GO:0051015; GO:0061564; GO:0098529,"axon development [GO:0061564]; axon extension [GO:0048675]; establishment of epithelial cell apical/basal polarity [GO:0045198]; intracellular signal transduction [GO:0035556]; locomotory behavior [GO:0007626]; neuromuscular junction development, skeletal muscle fiber [GO:0098529]; swimming behavior [GO:0036269]",actin filament [GO:0005884]; axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; membrane [GO:0016020]; myosin complex [GO:0016459]; synapse [GO:0045202],actin filament binding [GO:0051015]; ATP binding [GO:0005524]; GTPase activator activity [GO:0005096]; microfilament motor activity [GO:0000146]; zinc ion binding [GO:0008270],GO:0003774; GO:0003824; GO:0007163; GO:0008092; GO:0016853; GO:0030154; GO:0034330; GO:0098772; GO:0140657,cytoskeletal motor activity; catalytic activity; establishment or maintenance of cell polarity; cytoskeletal protein binding; isomerase activity; cell differentiation; cell junction organization; molecular function regulator activity; ATP-dependent activity
OG_00055,0.3825183989266394,OG_00055,FUN_000330-T1,Peve_00033547,Pocillopora_meandrina_HIv1___RNAseq.g29083.t1,three_way,89.4465,FUN_000330-T1,A0A3G2LGI8,,,,,54.5,2571.0,0.0,2154.8,sp|A0A3G2LGI8|TLN_OSCPE Talin OS=Oscarella pearsei OX=1940113 GN=TLN PE=1 SV=1,,,,,,
OG_01740,0.3820836861983352,OG_01740,FUN_007062-T1,Peve_00025326,Pocillopora_meandrina_HIv1___RNAseq.g20109.t1,three_way,70.79983333333334,FUN_007062-T1,Q8IX03,KIBRA_HUMAN,,Protein KIBRA (HBeAg-binding protein 3) (Kidney and brain protein) (KIBRA) (WW domain-containing protein 1),Homo sapiens (Human),29.0,1136.0,8.3e-51,204.1,sp|Q8IX03|KIBRA_HUMAN Protein KIBRA OS=Homo sapiens OX=9606 GN=WWC1 PE=1 SV=1,GO:0000122; GO:0003713; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0008285; GO:0016477; GO:0019900; GO:0030010; GO:0032386; GO:0032587; GO:0035329; GO:0035330; GO:0035331; GO:0035591; GO:0043410; GO:0046621; GO:0048471; GO:0060090,cell migration [GO:0016477]; establishment of cell polarity [GO:0030010]; hippo signaling [GO:0035329]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hippo signaling [GO:0035331]; negative regulation of organ growth [GO:0046621]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of MAPK cascade [GO:0043410]; regulation of DNA-templated transcription [GO:0006355]; regulation of hippo signaling [GO:0035330]; regulation of intracellular transport [GO:0032386],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587],kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; signaling adaptor activity [GO:0035591]; transcription coactivator activity [GO:0003713],GO:0005634; GO:0005829; GO:0006355; GO:0007163; GO:0043226; GO:0048870; GO:0060090; GO:0140110,nucleus; cytosol; regulation of DNA-templated transcription; establishment or maintenance of cell polarity; organelle; cell motility; molecular adaptor activity; transcription regulator activity
OG_00386,0.3814553894024755,OG_00386,FUN_001238-T1,Peve_00002842,Pocillopora_meandrina_HIv1___RNAseq.g2515.t2,three_way,45.375,FUN_001238-T1,Q8IVU1,,,,,32.5,517.0,1.1e-67,260.4,sp|Q8IVU1|IGDC3_HUMAN Immunoglobulin superfamily DCC subclass member 3 OS=Homo sapiens OX=9606 GN=IGDCC3 PE=1 SV=2,,,,,,
OG_07039,0.3808047337140385,OG_07039,FUN_032235-T1,Peve_00043486,Pocillopora_meandrina_HIv1___RNAseq.g24841.t1,three_way,59.83833333333334,,,,,,,,,,,,,,,,,
OG_01290,0.3806353176264245,OG_01290,FUN_005113-T1,Peve_00007463,Pocillopora_meandrina_HIv1___RNAseq.g8268.t1,three_way,72.56616666666666,FUN_005113-T1,O15945,ARNT_DROME,,Aryl hydrocarbon receptor nuclear translocator homolog (dARNT) (Hypoxia-inducible factor 1-beta) (Protein tango),Drosophila melanogaster (Fruit fly),57.4,378.0,5.4e-115,416.8,sp|O15945|ARNT_DROME Aryl hydrocarbon receptor nuclear translocator homolog OS=Drosophila melanogaster OX=7227 GN=tgo PE=1 SV=3,GO:0000122; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0006357; GO:0007417; GO:0007420; GO:0008286; GO:0008347; GO:0016348; GO:0017022; GO:0032869; GO:0032991; GO:0034751; GO:0043565; GO:0045676; GO:0045944; GO:0046982; GO:0048477; GO:0048736; GO:0071456; GO:0090575,appendage development [GO:0048736]; brain development [GO:0007420]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; central nervous system development [GO:0007417]; glial cell migration [GO:0008347]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; insulin receptor signaling pathway [GO:0008286]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of R7 cell differentiation [GO:0045676]; regulation of transcription by RNA polymerase II [GO:0006357],aryl hydrocarbon receptor complex [GO:0034751]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; myosin binding [GO:0017022]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0006355; GO:0008092; GO:0022414; GO:0043226; GO:0048856; GO:0048870; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cytoskeletal protein binding; reproductive process; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_10221,0.3803220715878879,OG_10221,FUN_043835-T1,Peve_00041794,Pocillopora_meandrina_HIv1___TS.g12323.t1,three_way,54.1065,,,,,,,,,,,,,,,,,
OG_06719,0.3802133885397039,OG_06719,FUN_031470-T1,Peve_00026552,Pocillopora_meandrina_HIv1___RNAseq.g5082.t1,three_way,68.5885,FUN_031470-T1,Q9JLC8,,,,,30.2,4722.0,0.0,1872.1,sp|Q9JLC8|SACS_MOUSE Sacsin OS=Mus musculus OX=10090 GN=Sacs PE=1 SV=2,,,,,,
OG_03562,0.3795394087555299,OG_03562,FUN_014710-T1,Peve_00004185,Pocillopora_meandrina_HIv1___TS.g27294.t1,three_way,91.096,FUN_014710-T1,Q5SPC5,OTOF_DANRE,,Otoferlin (Fer-1-like protein 2),Danio rerio (Zebrafish) (Brachydanio rerio),49.8,2026.0,0.0,1855.5,sp|Q5SPC5|OTOF_DANRE Otoferlin OS=Danio rerio OX=7955 GN=otof PE=3 SV=1,GO:0000139; GO:0001964; GO:0005509; GO:0005789; GO:0007009; GO:0007605; GO:0010996; GO:0016079; GO:0016082; GO:0016323; GO:0030672; GO:0035612; GO:0036465; GO:0042995; GO:0048787; GO:0050885,neuromuscular process controlling balance [GO:0050885]; plasma membrane organization [GO:0007009]; response to auditory stimulus [GO:0010996]; sensory perception of sound [GO:0007605]; startle response [GO:0001964]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle priming [GO:0016082]; synaptic vesicle recycling [GO:0036465],basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; presynaptic active zone membrane [GO:0048787]; synaptic vesicle membrane [GO:0030672],AP-2 adaptor complex binding [GO:0035612]; calcium ion binding [GO:0005509],GO:0016192; GO:0050877; GO:0061024; GO:0065003,vesicle-mediated transport; nervous system process; membrane organization; protein-containing complex assembly
OG_07404,0.3789675524185736,OG_07404,FUN_033855-T1,Peve_00039888,Pocillopora_meandrina_HIv1___RNAseq.g28422.t1,three_way,68.755,FUN_033855-T1,O75581,LRP6_HUMAN,,Low-density lipoprotein receptor-related protein 6 (LRP-6),Homo sapiens (Human),46.7,1685.0,2.9e-254,880.6,sp|O75581|LRP6_HUMAN Low-density lipoprotein receptor-related protein 6 OS=Homo sapiens OX=9606 GN=LRP6 PE=1 SV=2,GO:0005041; GO:0005102; GO:0005109; GO:0005576; GO:0005783; GO:0005886; GO:0006897; GO:0007204; GO:0007268; GO:0007399; GO:0009986; GO:0014029; GO:0014033; GO:0015026; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0030291; GO:0031410; GO:0031901; GO:0034392; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043434; GO:0045121; GO:0045202; GO:0045787; GO:0045893; GO:0045944; GO:0060070; GO:0071397; GO:0071542; GO:0072659; GO:0098609; GO:1904948; GO:1990851; GO:1990909,canonical Wnt signaling pathway [GO:0060070]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; chemical synaptic transmission [GO:0007268]; dopaminergic neuron differentiation [GO:0071542]; endocytosis [GO:0006897]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; response to peptide hormone [GO:0043434]; Wnt signaling pathway [GO:0016055],cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851],coreceptor activity [GO:0015026]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase inhibitor activity [GO:0030291]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147],GO:0005215; GO:0005576; GO:0005783; GO:0005886; GO:0006355; GO:0007155; GO:0016192; GO:0023052; GO:0030154; GO:0031410; GO:0038024; GO:0043226; GO:0048856; GO:0060089; GO:0072659; GO:0098772,transporter activity; extracellular region; endoplasmic reticulum; plasma membrane; regulation of DNA-templated transcription; cell adhesion; vesicle-mediated transport; signaling; cell differentiation; cytoplasmic vesicle; cargo receptor activity; organelle; anatomical structure development; molecular transducer activity; protein localization to plasma membrane; molecular function regulator activity
OG_00414,0.3789084255023305,OG_00414,FUN_001316-T1,Peve_00036964,Pocillopora_meandrina_HIv1___RNAseq.g2261.t1,three_way,53.97383333333333,FUN_001316-T1,Q8IVL1,,,,,36.1,388.0,7.2e-66,255.0,sp|Q8IVL1|NAV2_HUMAN Neuron navigator 2 OS=Homo sapiens OX=9606 GN=NAV2 PE=1 SV=3,,,,,,
OG_08131,0.3786809979465113,OG_08131,FUN_035891-T1,Peve_00029395,Pocillopora_meandrina_HIv1___RNAseq.g12008.t1,three_way,81.82483333333333,FUN_035891-T1,Q9WUU6,,,,,68.0,325.0,9.9e-122,438.3,sp|Q9WUU6|HNF4G_MOUSE Hepatocyte nuclear factor 4-gamma OS=Mus musculus OX=10090 GN=Hnf4g PE=2 SV=2,,,,,,
OG_02611,0.3786275477102628,OG_02611,FUN_010745-T1,Peve_00038409,Pocillopora_meandrina_HIv1___TS.g25690.t1,three_way,79.04633333333334,FUN_010745-T1,O75153,,,,,47.6,1302.0,0.0,1138.6,sp|O75153|CLU_HUMAN Clustered mitochondria protein homolog OS=Homo sapiens OX=9606 GN=CLUH PE=1 SV=2,,,,,,
OG_08411,0.3783403630338287,OG_08411,FUN_037062-T1,Peve_00018396,Pocillopora_meandrina_HIv1___RNAseq.g26779.t1,three_way,65.08266666666667,FUN_037062-T1,O95628,CNOT4_HUMAN,,CCR4-NOT transcription complex subunit 4 (EC 2.3.2.27) (CCR4-associated factor 4) (E3 ubiquitin-protein ligase CNOT4) (Potential transcriptional repressor NOT4Hp) (RING-type E3 ubiquitin transferase CNOT4),Homo sapiens (Human),48.8,441.0,2.6e-103,377.9,sp|O95628|CNOT4_HUMAN CCR4-NOT transcription complex subunit 4 OS=Homo sapiens OX=9606 GN=CNOT4 PE=1 SV=3,GO:0000289; GO:0003723; GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0030014; GO:0045652; GO:0051865,nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of megakaryocyte differentiation [GO:0045652]; ubiquitin-dependent protein catabolic process [GO:0006511],CCR4-NOT complex [GO:0030014]; cytosol [GO:0005829]; nucleus [GO:0005634],RNA binding [GO:0003723]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0005634; GO:0005829; GO:0016071; GO:0016740; GO:0043226; GO:0140096,"RNA binding; catalytic activity; nucleus; cytosol; mRNA metabolic process; transferase activity; organelle; catalytic activity, acting on a protein"
OG_04711,0.3772205601056336,OG_04711,FUN_022518-T1,Peve_00030465,Pocillopora_meandrina_HIv1___TS.g21661.t1,three_way,66.89816666666665,FUN_022518-T1,Q99996,AKAP9_HUMAN,,A-kinase anchor protein 9 (AKAP-9) (A-kinase anchor protein 350 kDa) (AKAP 350) (hgAKAP 350) (A-kinase anchor protein 450 kDa) (AKAP 450) (AKAP 120-like protein) (Centrosome- and Golgi-localized PKN-associated protein) (CG-NAP) (Protein hyperion) (Protein kinase A-anchoring protein 9) (PRKA9) (Protein yotiao),Homo sapiens (Human),36.4,291.0,1.9e-34,152.1,sp|Q99996|AKAP9_HUMAN A-kinase anchor protein 9 OS=Homo sapiens OX=9606 GN=AKAP9 PE=1 SV=4,GO:0003677; GO:0005102; GO:0005794; GO:0005795; GO:0005801; GO:0005813; GO:0005829; GO:0005856; GO:0007020; GO:0007165; GO:0007268; GO:0008076; GO:0015459; GO:0031116; GO:0031503; GO:0034237; GO:0034705; GO:0043025; GO:0043231; GO:0044307; GO:0044325; GO:0051602; GO:0051661; GO:0060090; GO:0060306; GO:0060307; GO:0071320; GO:0086091; GO:0097060; GO:0098909; GO:0098978; GO:0099104; GO:0099147; GO:1903358,cellular response to cAMP [GO:0071320]; chemical synaptic transmission [GO:0007268]; maintenance of centrosome location [GO:0051661]; microtubule nucleation [GO:0007020]; positive regulation of microtubule polymerization [GO:0031116]; protein-containing complex localization [GO:0031503]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of Golgi organization [GO:1903358]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization [GO:0060306]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to electrical stimulus [GO:0051602]; signal transduction [GO:0007165],centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic branch [GO:0044307]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; potassium channel complex [GO:0034705]; synaptic membrane [GO:0097060]; voltage-gated potassium channel complex [GO:0008076],DNA binding [GO:0003677]; molecular adaptor activity [GO:0060090]; potassium channel activator activity [GO:0099104]; potassium channel regulator activity [GO:0015459]; protein kinase A regulatory subunit binding [GO:0034237]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325],GO:0003677; GO:0005794; GO:0005815; GO:0005829; GO:0005856; GO:0007010; GO:0023052; GO:0043226; GO:0060090; GO:0098772,DNA binding; Golgi apparatus; microtubule organizing center; cytosol; cytoskeleton; cytoskeleton organization; signaling; organelle; molecular adaptor activity; molecular function regulator activity
OG_09037,0.3762291822335303,OG_09037,FUN_038638-T1,Peve_00013491,Pocillopora_meandrina_HIv1___RNAseq.g26490.t2,three_way,56.39266666666666,FUN_038638-T1,Q8WXD9,,,,,42.0,143.0,2e-27,126.7,sp|Q8WXD9|CSKI1_HUMAN Caskin-1 OS=Homo sapiens OX=9606 GN=CASKIN1 PE=1 SV=1,,,,,,
OG_04478,0.3761085731706505,OG_04478,FUN_021108-T1,Peve_00008861,Pocillopora_meandrina_HIv1___RNAseq.g4371.t1,three_way,84.41233333333334,FUN_021108-T1,Q15119,PDK2_HUMAN,,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 2) (PDH kinase 2) (PDKII)",Homo sapiens (Human),50.9,385.0,7.8e-108,392.1,"sp|Q15119|PDK2_HUMAN [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial OS=Homo sapiens OX=9606 GN=PDK2 PE=1 SV=2",GO:0004672; GO:0004740; GO:0005524; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006006; GO:0006111; GO:0006885; GO:0008286; GO:0010510; GO:0010565; GO:0010906; GO:0031670; GO:0034614; GO:0042593; GO:0042803; GO:0045254; GO:0050848; GO:0072332,cellular response to nutrient [GO:0031670]; cellular response to reactive oxygen species [GO:0034614]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; insulin receptor signaling pathway [GO:0008286]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of calcium-mediated signaling [GO:0050848]; regulation of gluconeogenesis [GO:0006111]; regulation of glucose metabolic process [GO:0010906]; regulation of ketone metabolic process [GO:0010565]; regulation of pH [GO:0006885],cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; pyruvate dehydrogenase complex [GO:0045254],ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740],GO:0003824; GO:0005654; GO:0005739; GO:0005829; GO:0005975; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleoplasm; mitochondrion; cytosol; carbohydrate metabolic process; transferase activity; organelle; catalytic activity, acting on a protein"
OG_08721,0.3757935411278424,OG_08721,FUN_037974-T1,Peve_00013894,Pocillopora_meandrina_HIv1___RNAseq.g26183.t1,three_way,56.88933333333333,FUN_037974-T1,Q3UHR0,,,,,27.2,746.0,2.1e-45,187.6,sp|Q3UHR0|BAHC1_MOUSE BAH and coiled-coil domain-containing protein 1 OS=Mus musculus OX=10090 GN=Bahcc1 PE=1 SV=2,,,,,,
OG_00843,0.3749725848472733,OG_00843,FUN_004094-T1,Peve_00003934,Pocillopora_meandrina_HIv1___RNAseq.g12638.t1,three_way,54.284,FUN_004094-T1,Q91062,,,,,21.7,927.0,2.1e-50,203.4,sp|Q91062|VIT_ICHUN Vitellogenin OS=Ichthyomyzon unicuspis OX=30308 PE=1 SV=1,,,,,,
OG_02786,0.3736892344510068,OG_02786,FUN_011741-T1,Peve_00015648,Pocillopora_meandrina_HIv1___RNAseq.g23891.t1,three_way,43.050666666666665,,,,,,,,,,,,,,,,,
OG_09269,0.3733781335799643,OG_09269,FUN_040075-T1,Peve_00021003,Pocillopora_meandrina_HIv1___RNAseq.g7690.t1,three_way,38.61383333333333,,,,,,,,,,,,,,,,,
OG_08022,0.3731525189347747,OG_08022,FUN_035677-T1,Peve_00002799,Pocillopora_meandrina_HIv1___RNAseq.g28144.t1,three_way,61.552,FUN_035677-T1,Q96I34,PP16A_HUMAN,,Protein phosphatase 1 regulatory subunit 16A (Myosin phosphatase-targeting subunit 3),Homo sapiens (Human),37.7,371.0,1.2e-26,123.2,sp|Q96I34|PP16A_HUMAN Protein phosphatase 1 regulatory subunit 16A OS=Homo sapiens OX=9606 GN=PPP1R16A PE=1 SV=1,GO:0004857; GO:0005737; GO:0005886; GO:0017020,,cytoplasm [GO:0005737]; plasma membrane [GO:0005886],enzyme inhibitor activity [GO:0004857]; myosin phosphatase regulator activity [GO:0017020],GO:0005886; GO:0098772,plasma membrane; molecular function regulator activity
OG_05647,0.3729347014483661,OG_05647,FUN_025365-T1,Peve_00040518,Pocillopora_meandrina_HIv1___RNAseq.g13333.t1,three_way,68.1275,FUN_025365-T1,Q62504,MINT_MOUSE,,Msx2-interacting protein (SMART/HDAC1-associated repressor protein) (SPEN homolog),Mus musculus (Mouse),40.8,610.0,6.4e-84,314.3,sp|Q62504|MINT_MOUSE Msx2-interacting protein OS=Mus musculus OX=10090 GN=Spen PE=1 SV=2,GO:0003697; GO:0003700; GO:0003714; GO:0003723; GO:0005634; GO:0007219; GO:0045892; GO:0045893; GO:0060816,negative regulation of DNA-templated transcription [GO:0045892]; Notch signaling pathway [GO:0007219]; positive regulation of DNA-templated transcription [GO:0045893]; random inactivation of X chromosome [GO:0060816],nucleus [GO:0005634],DNA-binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; transcription corepressor activity [GO:0003714],GO:0003677; GO:0003723; GO:0005634; GO:0006325; GO:0006355; GO:0043226; GO:0060090; GO:0140110,DNA binding; RNA binding; nucleus; chromatin organization; regulation of DNA-templated transcription; organelle; molecular adaptor activity; transcription regulator activity
OG_05647,0.3729347014483661,OG_05647,FUN_025365-T1,Peve_00040518,Pocillopora_meandrina_HIv1___RNAseq.g13333.t1,three_way,68.1275,FUN_025365-T1,Q62504,MINT_MOUSE,,Msx2-interacting protein (SMART/HDAC1-associated repressor protein) (SPEN homolog),Mus musculus (Mouse),61.2,188.0,5.7e-56,221.5,sp|Q62504|MINT_MOUSE Msx2-interacting protein OS=Mus musculus OX=10090 GN=Spen PE=1 SV=2,GO:0003697; GO:0003700; GO:0003714; GO:0003723; GO:0005634; GO:0007219; GO:0045892; GO:0045893; GO:0060816,negative regulation of DNA-templated transcription [GO:0045892]; Notch signaling pathway [GO:0007219]; positive regulation of DNA-templated transcription [GO:0045893]; random inactivation of X chromosome [GO:0060816],nucleus [GO:0005634],DNA-binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; transcription corepressor activity [GO:0003714],GO:0003677; GO:0003723; GO:0005634; GO:0006325; GO:0006355; GO:0043226; GO:0060090; GO:0140110,DNA binding; RNA binding; nucleus; chromatin organization; regulation of DNA-templated transcription; organelle; molecular adaptor activity; transcription regulator activity
OG_08165,0.372906807984794,OG_08165,FUN_035962-T1,Peve_00006624,Pocillopora_meandrina_HIv1___RNAseq.g12329.t1,three_way,87.42883333333333,FUN_035962-T1,Q9GYZ0,,,,,39.5,1065.0,2e-180,634.8,sp|Q9GYZ0|KIF15_STRPU Kinesin-like protein KIF15 OS=Strongylocentrotus purpuratus OX=7668 GN=KIF15 PE=1 SV=1,,,,,,
OG_07947,0.3721998248465927,OG_07947,FUN_035468-T1,Peve_00012132,Pocillopora_meandrina_HIv1___TS.g14397.t1,three_way,83.6845,FUN_035468-T1,Q8BH04,PCKGM_MOUSE,,"Phosphoenolpyruvate carboxykinase [GTP], mitochondrial (PEPCK-M) (EC 4.1.1.32)",Mus musculus (Mouse),65.5,611.0,6.100000000000001e-248,858.2,"sp|Q8BH04|PCKGM_MOUSE Phosphoenolpyruvate carboxykinase [GTP], mitochondrial OS=Mus musculus OX=10090 GN=Pck2 PE=1 SV=1",GO:0004613; GO:0005525; GO:0005739; GO:0005759; GO:0006090; GO:0006094; GO:0006107; GO:0030145; GO:0032024; GO:0032496; GO:0071333; GO:0071356; GO:0071548,cellular response to glucose stimulus [GO:0071333]; cellular response to tumor necrosis factor [GO:0071356]; gluconeogenesis [GO:0006094]; oxaloacetate metabolic process [GO:0006107]; positive regulation of insulin secretion [GO:0032024]; pyruvate metabolic process [GO:0006090]; response to dexamethasone [GO:0071548]; response to lipopolysaccharide [GO:0032496],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613],GO:0003824; GO:0005739; GO:0005975; GO:0016829; GO:0043226,catalytic activity; mitochondrion; carbohydrate metabolic process; lyase activity; organelle
OG_01161,0.3721861819729339,OG_01161,FUN_004780-T1,Peve_00037744,Pocillopora_meandrina_HIv1___RNAseq.g6689.t1,three_way,84.39833333333334,FUN_004780-T1,Q6P3J5,EF2_DANRE,,Elongation factor 2b (EF-2) (EC 3.6.5.-),Danio rerio (Zebrafish) (Brachydanio rerio),77.6,858.0,0.0,1342.8,sp|Q6P3J5|EF2_DANRE Elongation factor 2b OS=Danio rerio OX=7955 GN=eef2b PE=1 SV=1,GO:0003746; GO:0003924; GO:0005525; GO:0005634; GO:0005829; GO:0006414; GO:0043009; GO:0043022; GO:0071466; GO:1990904,cellular response to xenobiotic stimulus [GO:0071466]; chordate embryonic development [GO:0043009]; translational elongation [GO:0006414],cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746],GO:0003824; GO:0003924; GO:0005634; GO:0005829; GO:0016787; GO:0043226; GO:0048856,catalytic activity; GTPase activity; nucleus; cytosol; hydrolase activity; organelle; anatomical structure development
OG_09513,0.3717481866099438,OG_09513,FUN_041567-T1,Peve_00033111,Pocillopora_meandrina_HIv1___RNAseq.g15979.t1,three_way,54.623333333333335,FUN_041567-T1,Q924A2,,,,,27.8,752.0,2.7e-39,166.4,sp|Q924A2|CIC_MOUSE Protein capicua homolog OS=Mus musculus OX=10090 GN=Cic PE=1 SV=2,,,,,,
OG_09513,0.3717481866099438,OG_09513,FUN_041567-T1,Peve_00033111,Pocillopora_meandrina_HIv1___RNAseq.g15979.t1,three_way,54.623333333333335,FUN_041567-T1,Q924A2,,,,,36.9,187.0,1.8e-19,100.5,sp|Q924A2|CIC_MOUSE Protein capicua homolog OS=Mus musculus OX=10090 GN=Cic PE=1 SV=2,,,,,,
OG_00618,0.3715587139877923,OG_00618,FUN_001784-T1,Peve_00011611,Pocillopora_meandrina_HIv1___RNAseq.g2640.t1a,three_way,76.89133333333334,FUN_001784-T1,Q91ZR4,NEK8_MOUSE,,Serine/threonine-protein kinase Nek8 (EC 2.7.11.1) (Never in mitosis A-related kinase 8) (NimA-related protein kinase 8),Mus musculus (Mouse),40.8,650.0,1.2e-118,429.9,sp|Q91ZR4|NEK8_MOUSE Serine/threonine-protein kinase Nek8 OS=Mus musculus OX=10090 GN=Nek8 PE=1 SV=1,GO:0004674; GO:0005524; GO:0005737; GO:0005813; GO:0005929; GO:0007368; GO:0007507; GO:0009887; GO:0035330; GO:0046872; GO:0097543; GO:0097546; GO:0106310,animal organ morphogenesis [GO:0009887]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; regulation of hippo signaling [GO:0035330],centrosome [GO:0005813]; ciliary base [GO:0097546]; ciliary inversin compartment [GO:0097543]; cilium [GO:0005929]; cytoplasm [GO:0005737],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005815; GO:0005929; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; microtubule organizing center; cilium; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_01466,0.3714911224276757,OG_01466,FUN_006002-T1,Peve_00036060,Pocillopora_meandrina_HIv1___RNAseq.g19927.t1,three_way,76.86133333333333,FUN_006002-T1,A0A1U8QWA2,ATR12_EMENI,,Glycine betaine reductase ATRR (Nonribosomal peptide synthetase-like protein ATRR) [Includes: Carboxylic acid reductase (EC 1.2.1.-); Aldehyde reductase (EC 1.1.1.-)],Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) (Aspergillus nidulans),38.2,1317.0,3.3e-237,823.5,sp|A0A1U8QWA2|ATR12_EMENI Glycine betaine reductase ATRR OS=Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) OX=227321 GN=ATRR PE=1 SV=1,GO:0009058; GO:0016491; GO:0031177,biosynthetic process [GO:0009058],,oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177],GO:0003824; GO:0016491,catalytic activity; oxidoreductase activity
OG_07938,0.3711046531396928,OG_07938,FUN_035444-T1,Peve_00002174,Pocillopora_meandrina_HIv1___RNAseq.g27111.t1,three_way,85.51933333333334,FUN_035444-T1,Q8BZZ3,WWP1_MOUSE,,NEDD4-like E3 ubiquitin-protein ligase WWP1 (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase WWP1) (WW domain-containing protein 1),Mus musculus (Mouse),57.0,910.0,8.499999999999999e-234,811.6,sp|Q8BZZ3|WWP1_MOUSE NEDD4-like E3 ubiquitin-protein ligase WWP1 OS=Mus musculus OX=10090 GN=Wwp1 PE=1 SV=2,GO:0004842; GO:0005634; GO:0005829; GO:0005886; GO:0016567; GO:0030217; GO:0030324; GO:0043161; GO:0045892; GO:0061630; GO:0070161,lung development [GO:0030324]; negative regulation of DNA-templated transcription [GO:0045892]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; T cell differentiation [GO:0030217],anchoring junction [GO:0070161]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842],GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0006355; GO:0016740; GO:0030154; GO:0030163; GO:0043226; GO:0048856; GO:0140096,"immune system process; catalytic activity; nucleus; cytosol; plasma membrane; regulation of DNA-templated transcription; transferase activity; cell differentiation; protein catabolic process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_01452,0.3710685944627567,OG_01452,FUN_005908-T1,Peve_00038389,Pocillopora_meandrina_HIv1___RNAseq.g19573.t1,three_way,84.7165,FUN_005908-T1,P23634,AT2B4_HUMAN,,Plasma membrane calcium-transporting ATPase 4 (PMCA4) (EC 7.2.2.10) (Matrix-remodeling-associated protein 1) (Plasma membrane calcium ATPase isoform 4) (Plasma membrane calcium pump isoform 4),Homo sapiens (Human),59.0,1089.0,0.0,1226.8,sp|P23634|AT2B4_HUMAN Plasma membrane calcium-transporting ATPase 4 OS=Homo sapiens OX=9606 GN=ATP2B4 PE=1 SV=2,GO:0003407; GO:0005388; GO:0005516; GO:0005524; GO:0005739; GO:0005886; GO:0005901; GO:0005929; GO:0006357; GO:0006874; GO:0007283; GO:0010629; GO:0014832; GO:0015085; GO:0016020; GO:0016323; GO:0016525; GO:0016887; GO:0017080; GO:0019901; GO:0021766; GO:0030018; GO:0030165; GO:0030315; GO:0030317; GO:0030346; GO:0032991; GO:0034220; GO:0036064; GO:0036126; GO:0036487; GO:0038060; GO:0043231; GO:0043537; GO:0045019; GO:0045121; GO:0046872; GO:0048787; GO:0050998; GO:0051480; GO:0051599; GO:0070588; GO:0070885; GO:0071872; GO:0071878; GO:0097110; GO:0097228; GO:0097553; GO:0098703; GO:0098736; GO:0098978; GO:0150104; GO:1900082; GO:1901660; GO:1902305; GO:1902548; GO:1902806; GO:1903078; GO:1903243; GO:1903249; GO:1903779; GO:1905145,calcium ion export [GO:1901660]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; cellular response to acetylcholine [GO:1905145]; cellular response to epinephrine stimulus [GO:0071872]; flagellated sperm motility [GO:0030317]; hippocampus development [GO:0021766]; intracellular calcium ion homeostasis [GO:0006874]; monoatomic ion transmembrane transport [GO:0034220]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071878]; negative regulation of angiogenesis [GO:0016525]; negative regulation of arginine catabolic process [GO:1900082]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of cellular response to vascular endothelial growth factor stimulus [GO:1902548]; negative regulation of citrulline biosynthetic process [GO:1903249]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of the force of heart contraction [GO:0098736]; neural retina development [GO:0003407]; nitric oxide-cGMP-mediated signaling [GO:0038060]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of cardiac conduction [GO:1903779]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hydrostatic pressure [GO:0051599]; spermatogenesis [GO:0007283]; transport across blood-brain barrier [GO:0150104]; urinary bladder smooth muscle contraction [GO:0014832],basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; protein-containing complex [GO:0032991]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228]; T-tubule [GO:0030315]; Z disc [GO:0030018],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calcium ion transmembrane transporter activity [GO:0015085]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; nitric-oxide synthase binding [GO:0050998]; nitric-oxide synthase inhibitor activity [GO:0036487]; P-type calcium transporter activity [GO:0005388]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein phosphatase 2B binding [GO:0030346]; scaffold protein binding [GO:0097110]; sodium channel regulator activity [GO:0017080],GO:0003012; GO:0003013; GO:0003824; GO:0005215; GO:0005739; GO:0005815; GO:0005886; GO:0005929; GO:0006355; GO:0007018; GO:0016787; GO:0022414; GO:0043226; GO:0048856; GO:0048870; GO:0055085; GO:0098772; GO:0140657,muscle system process; circulatory system process; catalytic activity; transporter activity; mitochondrion; microtubule organizing center; plasma membrane; cilium; regulation of DNA-templated transcription; microtubule-based movement; hydrolase activity; reproductive process; organelle; anatomical structure development; cell motility; transmembrane transport; molecular function regulator activity; ATP-dependent activity
